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Abstract 23 
Uropathogenic E. coli (UPEC) is the main etiological agent of urinary tract infections (UTI). 24 
Little is known about interactions between UPEC and the inflammasome, a key innate immune 25 
pathway. Here we show that UPEC strains CFT073 and UTI89 trigger inflammasome activation 26 
and lytic cell death in human macrophages. Several other UPEC strains, including two multidrug 27 
resistant ST131 isolates, did not kill macrophages. In mouse macrophages, UTI89 triggered cell 28 
death only at a high MOI, and CFT073-mediated inflammasome responses were completely 29 
NLRP3-dependent. Surprisingly, CFT073- and UTI89-mediated responses only partially 30 
depended on NLRP3 in human macrophages. In these cells, NLRP3 was required for IL-1β 31 
maturation, but contributed only marginally to cell death. Similarly, caspase-1 inhibition did not 32 
block cell death in human macrophages. In keeping with such differences, the pore forming toxin 33 
α-hemolysin mediated a substantial proportion of CFT073-triggered IL-1β secretion in mouse 34 
but not human macrophages. There was also a more substantial α-hemolysin-independent cell 35 
death response in human versus mouse macrophages. Thus, in mouse macrophages, CFT073-36 
triggered inflammasome responses are completely NLRP3-dependent, and largely α-hemolysin-37 
dependent. In contrast, UPEC activates an NLRP3-independent cell death pathway and an α-38 
hemolysin-independent IL-1β secretion pathway in human macrophages. This has important 39 
implications for understanding UTI in humans.  40 
 41 
 42 
 43 
44 
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Introduction 45 
Uropathogenic Escherichia coli (UPEC) is estimated to cause up to 80% of community-acquired 46 
and 65% of nosocomial urinary tract infections (UTI), making it the single most important 47 
etiological agent of this highly prevalent infectious disease
1
. UTI typically involves infection of 48 
the bladder (cystitis) or kidneys (pyelonephritis), and can also lead to renal scarring and sepsis
1, 2
. 49 
Asymptomatic bacteriuria (ABU), caused by various etiologic agents, is also common
3
.  50 
 51 
Mouse UTI models, as well as genetic associations within patient cohort studies, have helped to 52 
pinpoint the roles of specific innate immune pathways in defense against uropathogens
2
. Such 53 
studies have highlighted the importance of members of the Toll-like Receptor family in 54 
controlling bacterial growth and dissemination, as well as causing symptoms and pathology. At 55 
the cellular level, roles of the urothelium and neutrophils in innate defence and host subversion 56 
during UTI are well established. However, surprisingly little is known about the roles of 57 
monocytes and macrophages in these processes
4
. A recent study by Schiwon et al. dissected the 58 
role of different macrophage populations in a mouse UTI model and unraveled complex 59 
interactions of sentinel and helper macrophages governing antimicrobial actions of neutrophils
5
. 60 
We previously demonstrated that some UPEC strains can survive for up to 24 h in murine bone 61 
marrow-derived macrophages (BMM) within LAMP1
+
 compartments
6
, reminiscent of quiescent 62 
intracellular reservoirs observed in epithelial cells that may facilitate recurrent infection. Thus, 63 
the role of myeloid cells in UPEC infection may not always be protective. 64 
 65 
Upon detection of cellular stress and/or microbial products, some Nod-like-receptor (NLR) 66 
family members, as well as the PYHIN-family member AIM2, form large cytoplasmic 67 
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multiprotein complexes known as inflammasomes. Inflammasomes have important functions in 68 
many bacterial infections
7
, as well as in chronic diseases
8, 9
. The NLR-family comprises twenty-69 
two genes in humans and more than thirty in mice, and can be phylogenetically grouped into the 70 
NLRP, IPAF and NOD sub-families
10
. The NLRP family members NLRP1 and NLRP3, as well 71 
as the IPAF family member NLRC4, can all initiate inflammasome formation. Most NLRP 72 
family members contain a C-terminal leucine rich repeat that is involved in danger sensing, a 73 
central nucleotide-binding and oligomerisation domain, and an N-terminal pyrin domain that 74 
relays downstream signalling. NLRC4 has a similar domain structure, but contains an N-terminal 75 
caspase recruitment domain (CARD), rather than a pyrin domain. Upon activation, NLRPs 76 
oligomerise and cluster into a cytoplasmic complex with the adapter protein ASC and the 77 
protease caspase-1, facilitating its autocatalytic cleavage and activation. Active caspase-1 is 78 
required for maturation and secretion of the pro-inflammatory IL-1 family cytokines, IL-1β and 79 
IL-18. One of the many functions of IL-1β is to facilitate neutrophil and macrophage recruitment 80 
to sites of infection. In addition to mediating cytokin  processing, inflammasome activation also 81 
initiates a programmed, pro-inflammatory form of cell death called pyroptosis. Pyroptotic cell 82 
death is thought to eliminate the intracellular replication niche of pathogens that infect 83 
macrophages (e.g. Shigella, Salmonella, Legionella and Listeria) and to re-expose them to 84 
antimicrobial effector functions
7, 11
.  85 
 86 
Among the different pathogenic E. coli subtypes, enterohemorrhagic E. coli O157:H7, which 87 
causes severe enteritis, triggers inflammasome activation
12
. However, until very recently no 88 
studies had investigated inflammasome involvement in UPEC recognition or UTI. In this study, 89 
we show that the genome-sequenced UPEC reference strains CFT073 and UTI89 trigger 90 
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inflammasome activation and rapid cell death in macrophages, whereas others do not. Moreover, 91 
we define key mechanistic differences between human and mouse macrophages in the host 92 
recognition pathways and bacterial factors that initiate these responses. Our findings of 93 
fundamental differences between different UPEC strains in inflammasome engagement, as well 94 
as between human and mouse innate immune recognition pathways for UPEC, have major 95 
implications for understanding and modeling UTI pathogenesis. 96 
 97 
 98 
 99 
 100 
 101 
 102 
 103 
 104 
 105 
 106 
 107 
 108 
 109 
 110 
 111 
 112 
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Results 114 
 115 
UPEC strains CFT073 and UTI89 cause rapid cell death in macrophages 116 
Given the paucity of information on interactions between UPEC and macrophages, we 117 
investigated whether the survival of human monocyte-derived macrophages (HMDM) was 118 
affected by different UPEC strains. We analyzed strains associated with different UTI severity, 119 
including the reference strains CFT073 (a blood culture isolate from a patient with 120 
pyelonephritis)
13
 and UTI89 (a urine isolate from a patient with recurrent cystitis)
14
, the sequence 121 
type (ST) 131 strains EC958
15, 16
 and  MS3179 (urine isolates from patients with UTI) and the 122 
asymptomatic bacteriuria (ABU) strains 83972 and VR50
17, 18
. These experiments revealed that 123 
only CFT073 and UTI89 caused rapid, lytic cell death by 2 h post-infection as assessed by LDH 124 
release (Fig. 1A). Cell death was further increased by 24 h post-infection (Fig. 1B). A direct 125 
comparison of HMDM with murine BMM over a multiplicity of infection (MOI) range 126 
confirmed that mouse macrophages were also susceptible to CFT073-induced cell death (Fig. 127 
1C). In BMM, UTI89 did not trigger cell death, except at the highest MOI used (MOI 100, Fig. 128 
1C). This is consistent with our previous findings that UTI89 can survive for up to 24 h within 129 
BMM
6, 19
. To investigate whether UPEC-mediated cell death is a macrophage-specific 130 
phenomenon, the response to CFT073, UTI89 and MS3179 was also analyzed in PMA-131 
differentiated THP-1 cells (a human macrophage-like cell line), murine peritoneal cavity cells 132 
(PCC, which are predominantly comprised of resident peritoneal macrophages
20
) and two human 133 
bladder epithelial cell lines (5637 and T24) commonly used to study UPEC infection in vitro 134 
(Fig. 1D). PMA-differentiated THP-1 cells showed a similar response to HMDM. CFT073 also 135 
triggered cell death in PCC, whereas the effect of UTI89 was much weaker, similar to the 136 
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findings with mouse BMM (compare Fig. 1C). The ST131 isolate MS3179 did not trigger cell 137 
death in any of the cell types tested, and the two epithelial cell lines were not killed efficiently by 138 
any of the UPEC strains at an MOI of 10 at 2 h post-infection (Fig. 1D). However, 24 h exposure 139 
of epithelial cell lines to a very high MOI (MOI 1000) of all UPEC strains did result in some cell 140 
death (Fig. S1). Collectively, these data demonstrate substantial variability in the capacity of 141 
different UPEC strains to elicit macrophage cell death. 142 
 143 
UPEC-mediated macrophage cell death correlates with inflammasome activation 144 
To investigate potential involvement of the inflammasome pathway in cell death, we first 145 
examined the capacity of UPEC strains to trigger IL-1β release from LPS-primed macrophages. 146 
LPS priming was performed to boost pro-IL-1β levels, allowing the use of IL-1β release as a 147 
marker for inflammasome activation with minimal interference by rapid cell death or by other 148 
confounding processes such as suppression of cytokine production by some UPEC strains
21
. 149 
Indeed, we found that, whereas CFT073, UTI89 and MS3179 all elicited similar levels of 150 
secreted TNF-α from BMM, this response was greatly reduced in HMDM infected with strains 151 
triggering rapid cell death (CFT073, UTI89) as compared to MS3179 that did not cause cell 152 
death (Fig. S2A). Thus, TNF-α release inversely correlated with UPEC-induced rapid cell death 153 
in HMDM, as might be expected given that this cytokine must be synthesized prior to its release. 154 
In the case of IL-1β release from LPS-primed cells that already express pro-IL-1β, there was a 155 
clear correlation with induction of cell death in all cases. In human macrophages (HMDM and 156 
PMA-differentiated THP-1 cells), both CFT073 and UTI89 (MOI 10) triggered IL-1β release 157 
(Fig. 2A and S2B). In contrast, CFT073 but not UTI89 (MOI 10) elicited IL-1β release from 158 
LPS-primed mouse macrophages (BMM and PCC) (Fig. 2A and S2C), consistent with the 159 
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failure of UTI89 to trigger robust cell death in mouse macrophages at low MOI (compare Fig. 160 
1C and 1D). Also consistent with the cell death data, the ST131 strain MS3179 did not trigger 161 
IL-1β release from LPS-primed macrophages of either human or murine origin. LPS-primed 162 
epithelial cell lines did not release IL-1β in response to any of the UPEC strains tested (Fig. 163 
S2B). Similar patterns were observed for caspase-1 cleavage; both CFT073 and UTI89 triggered 164 
comparable capase-1 cleavage in human macrophages (Fig. 2B), whilst in mouse macrophages 165 
the response to CFT073 was much more pronounced than for UTI89 (Fig. 2B). Another hallmark 166 
of inflammasome activation, the formation of ASC specks, was also apparent in CFT073- and 167 
UTI89-infected human macrophages, whereas the ST131 strain MS3179 did not elicit this effect 168 
(Fig. 2C). Furthermore, infection with the two ASC speck-inducing UPEC strains (i.e. CFT073 169 
and UTI89) appeared to induce morphological changes and loss of nuclear integrity in HMDM, 170 
as visualized by actin and DNA staining in the same samples (Fig. 2C).   171 
 172 
CFT073-mediated cell death in murine macrophages is completely dependent on the 173 
NLRP3 inflammasome  174 
Causality of inflammasome activation and cell death in BMM was analysed using macrophages 175 
deficient for NLRP3 and NLRC4 (two NLRs most commonly activated by bacterial infection
7
), 176 
the inflammasome adaptor protein ASC, or the inflammatory caspases, caspase-1 and -11. Since 177 
UTI89 did not trigger pronounced inflammasome activation in mouse macrophages at an MOI of 178 
10, only CFT073 was assessed. CFT073-mediated caspase-1 cleavage was completely dependent 179 
on NLRP3 and ASC, but did not require NLRC4 (Fig. 3A). As expected, the positive controls 180 
nigericin and Salmonella enterica serovar Typhimurium (S. Typhimurium) strain SL1344 acted 181 
via NLRP3 and NLRC4, respectively (Fig. 3A). Analysis of LDH release confirmed that 182 
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NLRP3, ASC and Caspase-1/11 were required for CFT073-mediated cell death (Fig. 3B). These 183 
inflammasome components were also indispensable for CFT073-triggered IL-1β release from 184 
LPS-primed BMM (Fig. 3C). As with caspase-1 cleavage, NLRC4-deficiency did not affect 185 
LDH or IL-1β release upon infection with CFT073. Again, the positive controls for NLRP3, 186 
ASC and caspase-1 involvement (nigericin), and NLRC4 and caspase-1 involvement (S. 187 
Typhimurium), behaved as expected. ASC was dispensable for S. Typhimurium-mediated cell 188 
death (Fig. 3B) as previously reported
22
, and NLRP3, ASC and caspase-1/11 were indispensable 189 
for nigericin-triggered IL-1β release (Fig. 3C). S. Typhimurium-triggered IL-1β release was 190 
partially dependent on NLRP3 and ASC, and completely dependent on NLRC4 and caspase-191 
1/11. Hence, rapid cell death and IL-1β secretion triggered by CFT073 in mouse macrophages is 192 
dependent on NLRP3, ASC and caspase-1 and/or -11.  193 
 194 
In human macrophages, UPEC-mediated IL-1β secretion is dependent on NLRP3, whereas 195 
cell death is primarily NLRP3-independent 196 
We next investigated NLRP3 involvement in human macrophage responses to UPEC using 197 
MCC950, a recently described NLRP3 inhibitor that does not affect AIM2, NLRP1 or NLRC4-198 
mediated inflammasome activation
23
. Surprisingly, in LPS-primed HMDM, MCC950 blocked 199 
nigericin-triggered cell death, but had little effect on CFT073-triggered cell death in cells from 200 
most donors examined (Fig. 4A, Table S1). In contrast, MCC950 significantly reduced both 201 
nigericin- and CFT073-triggered IL-1β release from LPS-primed HMDM (Fig. 4B). Similar 202 
observations were apparent for UTI89, where MCC950 had only modest effects in reducing 203 
UTI89-triggered cell death for HMDM from 3 out of 4 donors (Table S1). This suggests that 204 
there are differences between human and mouse macrophages in NLRP3 responses to UPEC. 205 
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Indeed, a direct comparison revealed that, whereas MCC950 completely inhibited responses to 206 
nigericin in both HMDM and BMM, CFT073-mediated cell death was only blocked in mouse 207 
macrophages (Fig. S3A). Moreover, LPS priming had no apparent effect on NLRP3-dependency 208 
of CFT073-mediated cell death in human or mouse macrophages. In contrast to differential 209 
effects on cell death, MCC950 inhibited CFT073-triggered IL-1β release in both LPS-primed 210 
HMDM and BMM, albeit more effectively in BMM (Fig. S3B). The level of NLRP3-211 
dependence for CFT073-triggered IL-1β release varied between cells from different donors 212 
(Table S1), and MCC950 never completely abolished IL-1β release, as was the case for 213 
nigericin. We therefore investigated the possibility that the residual IL-1β response detected by 214 
ELISA might be due to the release of unprocessed IL-1β, as a consequence of cell death. Indeed, 215 
analysis of concentrated cell culture supernatants by immunoblotting revealed that treatment 216 
with MCC950 completely blocked release of mature IL-1β from CFT073-infected HMDM, 217 
whereas pro-IL-1β was still present in culture supernatants (Fig. 4C). We also monitored ASC 218 
speck formation upon NLRP3 inhibition in HMDM. In these experiments, the NLRP3 inhibitor 219 
MCC950 completely blocked nigericin- but not S. Typhimurium-triggered ASC speck formation 220 
(Fig. 4D). MCC950 substantially reduced, but did not ablate, CFT073- and UTI89-induced ASC 221 
speck formation in all experiments (Fig. 4D). 222 
 223 
To further investigate inflammasome involvement in human macrophages, the effect of the 224 
caspase-1 specific inhibitor VX-765
24
 on CFT073-triggered cell death in human and mouse 225 
macrophages was examined. VX-765 effectively blocked CFT073- and LPS/nigericin-triggered 226 
cell death and IL-1β release by LPS-primed BMM at 2 h post-infection (Fig. 5A-B). However, 227 
similar to the observations with MCC950, VX-765 reduced CFT073-mediated IL-1β release 228 
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from LPS-primed HMDM, but did not affect cell death. Control experiments confirmed that both 229 
inhibitors blocked cleavage and release of caspase-1 in response to CFT073 infection and 230 
LPS/nigericin stimulation in HMDM and BMM (Fig. 5C-D). Together, these findings indicate 231 
that (1) the NLRP3 inflammasome drives UPEC-triggered IL-1β maturation in human 232 
macrophages; and (2) an NLRP3-independent pathway is the primary mediator of UPEC-233 
triggered cell death in human macrophages.  234 
 235 
To independently verify that an NLRP3-independent pathway mediates UPEC-triggered cell 236 
death, we used THP-1 defNLRP3 cells, which stably express an NLRP3 shRNA and have 237 
reduced NLRP3 expression compared to a control cell line (THP-1 Null) transfected with an 238 
‘empty’ construct (Fig. 6A). Caspase-1 processing in THP-1 defNLRP3 cells responding to 239 
CFT073, UTI89 or nigericin was greatly reduced, whereas caspase-1 p20 was still detectable at 240 
high levels after infection with S. Typhimurium. In these cells, CFT073 and UTI89 still triggered 241 
substantial cell death, whereas nigericin did not (Fig. 6B). Again, LPS priming had no effect on 242 
the degree of NLRP3 dependency of UPEC-mediated cell death, although it did appear to reduce 243 
the effect of NLRP3-knockdown in the nigericin control. As expected, no reduction in cell death 244 
was observed in defNLRP3 cells when using S. Typhimurium as an NLRP3-independent trigger 245 
for cell death. Collectively, these data suggest the involvement of another NLRP3-independent, 246 
cell death pathway triggered by UPEC. 247 
 248 
α-hemolysin is the main factor in CFT073 triggering cell death and IL-1β release in mouse 249 
but not human macrophages 250 
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The capacity for CFT073 and UTI89 to trigger human macrophage cell death was also conferred 251 
by culture supernatants (Fig. S4). Crude biochemical analysis indicated that the factor(s) 252 
responsible were heat- and protease-sensitive, and with a likely molecular weight of greater than 253 
30 kDa. Candidate proteins mediating cell death and/or IL-1β secretion included the pore 254 
forming toxin α-hemolysin, as well as serine-protease autotransporter toxins (Sat and Vat). 255 
Genes encoding all three toxins are present in CFT073, while UTI89 contains the hlyCABD (α-256 
hemolysin operon) and vat genes. To test the involvement of these three toxins in triggering the 257 
inflammasome response, we generated a series of CFT073 mutants deleted for genes encoding 258 
each individual toxin and a triple-mutant deficient in the ability to produce all three toxins. 259 
Compared to wild type CFT073, the α-hemolysin mutant (CFT073∆hlyA) was greatly impaired 260 
in its ability to trigger cell death of mouse macrophages (~30% of wild type) and, to a lesser 261 
extent, of human macrophages (~60% of wild type) when macrophages were exposed to an MOI 262 
of 10 (Fig. 7A). CFT073 sat- and vat- mutants were very modestly compromised for their ability 263 
to trigger mouse and human macrophage cell death. However, no additive effect was observed, 264 
as the triple-mutant showed no difference to the CFT073∆hlyA single mutant in this assay. 265 
Similar observations were made at an MOI of 100 with both CFT073 and UTI89 (Fig. 7B). In 266 
this case, cell death induced by CFT073 and UTI89 was almost completely hlyA-independent in 267 
HMDM (cell death for hlyA mutants was ~85% of the wild type strains), whereas in BMM the 268 
response was largely hlyA-dependent (~30% and 40% of wild type strains). Intriguingly, analysis 269 
of IL-1β release revealed a striking difference between human and mouse macrophages with 270 
respect to triggering by α-hemolysin. Whereas IL-1β levels were substantially reduced in BMM 271 
responding to CFT073∆hlyA compared to wild type CFT073, deletion of hlyA had no effect on 272 
HMDM responses (Fig. 7C). Again, we analysed cleavage of released IL-1β by western blot and 273 
Page 13 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
 
 13
found that in HMDM levels of cleaved IL-1β were similar in samples infected with CFT073 and 274 
CFT073∆hlyA (Fig. 7D). In contrast, CFT073∆hlyA was drastically impaired in its ability to 275 
induce the release of cleaved IL-1β in BMM. Deletion of sat or vat had no effect on IL-276 
1β release from either human or mouse macrophages, and the response to the triple-mutant was 277 
again identical to that of the hlyA single-mutant. Thus, α-hemolysin is the primary, but not only, 278 
mediator of cell death and IL-1β release in mouse macrophages. Moreover, generation of mature 279 
IL-1β was completely dependent on α-hemolysin. By contrast, in the human macrophage 280 
response to UPEC, α-hemolysin does not contribute to IL-1β release or cleavage, and plays a 281 
lesser role in rapid cell death. These differential effects of α-hemolysin further highlight the 282 
divergent UPEC recognition pathways of human and mouse macrophages. In summary, UPEC 283 
triggers both NLRP3-independent cell death and α-hemolysin-independent IL-1β processing in 284 
human macrophages, thus indicating that additional host and pathogen-derived factors are likely 285 
to be important in the macrophage response to UPEC. 286 
 287 
  288 
289 
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Discussion 290 
In this study, we demonstrate that some UPEC strains can trigger both NLRP3-dependent 291 
inflammasome activation and rapid cell death in macrophages. We also provide important 292 
insights into these processes in the context of similarities and differences between human and 293 
mouse macrophage responses to UPEC. Other E. coli, including enterohemorrhagic E. coli 294 
isolates
12
 as well as non-pathogenic or commensal stains
25, 26
, have been reported to activate 295 
inflammasomes by a variety of different mechanisms involving several bacterial factors. These 296 
include nucleic acids
27
 and protein toxins (enterohemolysin
12
 and heat-labile enterotoxin
28
) 297 
acting via NLRP3, the T3SS rod protein EprJ
29
 and flagellin
25
 acting via NLRC4 and 298 
(intracellular) LPS
30
 acting via non-canonical inflammasomes. Our study adds to this literature 299 
by identifying UPEC α-hemolysin-dependent and -independent mechanisms of inflammasome 300 
activation in macrophages.  301 
 302 
It remains unclear as to what roles UPEC-mediated inflammasome activation has in different 303 
pathophysiological contexts. Two out of the four strains that did not elicit inflammasome 304 
activation are associated with ABU
17, 18
, whilst the remaining two belong to the globally 305 
disseminated fluoroquinolone-resistant fimH30/clade C ST131 lineage that is frequently 306 
associated with symptomatic infection
16, 31
. The two inflammasome-activating strains are also 307 
associated with UTI pathology. Hence, the capacity for inflammasome activation is variable, 308 
further highlighting the genetic diversity that exists amongst different UPEC isolates. Since the 309 
capacity to trigger inflammasome activation and macrophage cell death was not common to all 310 
UPEC strains, some UPEC strains may have gained inflammasome-activating factors as a 311 
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component of their virulence armoury or lost these to avoid host detection. In the case of the 312 
former, candidate virulence factors included the pore forming toxin α-hemolysin
32
, as well as 313 
serine-protease autotransporter toxins (Sat and Vat) that are known to elicit cytotoxic effects on 314 
epithelial cells
33
, and for which the genes are present in CFT073 (hlyA, sat, vat) and UTI89 315 
(hlyA, vat), but not 83972, VR50
34
 or EC958
15
. Mutation of all three factors in CFT073 revealed 316 
that only the absence of α-hemolysin substantially reduced inflammasome responses in mouse 317 
macrophages. Intriguingly, however, CFT073-triggered IL-1β release and cleavage was 318 
completely independent of α-hemolysin in human macrophages, and there was also a 319 
pronounced α-hemolysin-independent cell death pathway. This finding points towards 320 
fundamentally different recognition mechanisms for these UPEC strains in human versus mouse 321 
macrophages, yet conservation in the overall outcomes. Whether this extends to other cell types 322 
needs to be further examined, given a recent report on E. coli α-hemolysin triggering IL-323 
1β secretion in human urothelial cells
35
, an earlier study showing a similar phenomenon in 324 
human monocytes
36
 and well documented cell type-specific effects of α-hemolysin
32
. 325 
 326 
Our aim to characterize the specific inflammasome involved in UPEC recognition led us to study 327 
the response of mouse macrophages as a more tractable genetic system, as compared to human 328 
macrophages. Initial experiments revealed that mouse and human macrophages seemed to 329 
respond similarly with regard to induction of cell death, caspase-1 cleavage and IL-1β secretion 330 
upon infection with CFT073. In the case of UTI89, a much less pronounced response was 331 
observed in mouse macrophages compared to human macrophages when using a low MOI (MOI 332 
10). Nonetheless, a 10-fold higher MOI did initiate some cell death in these cells. In contrast, 333 
both CFT073 and UTI89 had similar effects on human macrophages. The conservation between 334 
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human and mouse macrophage responses to CFT073 led us to focus on this particular strain for 335 
the identification of host mechanisms mediating cellular responses. NLRP3, ASC and the 336 
inflammatory caspases (1 and/or 11) were indispensable for CFT073-mediated rapid lytic cell 337 
death and IL-1β secretion in mouse BMM, while a role for NLRC4 was excluded. These 338 
findings are consistent with a very recent study showing that UTI89 induces moderate IL-1β 339 
release from mouse macrophages in an NLRP3-dependent manner, albeit under different 340 
experimental conditions
37
. 341 
 342 
The conclusion that the acute CFT073-mediated inflammasome response leading to cell death 343 
and IL-1β secretion in BMM was absolutely dependent on NLRP3 was also supported by 344 
experiments using small molecule inhibitors of NLRP3 (MCC950) and caspase-1 (VX-765). 345 
However, primary human macrophages that were analysed in parallel showed a remarkably 346 
different response. The NLRP3 and caspase-1 inhibitors substantially reduced or blocked IL-1β 347 
release from HMDM in response to UPEC infection or the NLRP3 agonist nigericin, 348 
respectively. In contrast, UPEC-triggered cell death was largely unaffected by either inhibitor. 349 
Although analysis of HMDM generated from several donors revealed some variation in the level 350 
of NLRP3-dependence, the overall conclusion is that in human macrophages cell death is 351 
NLRP3-independent, whereas IL-1β cleavage was shown to be completely NLRP3-dependent. 352 
Interestingly, LPS-primed HMDMs released unprocessed IL-1β upon UPEC infection, even 353 
when the NLRP3 inflammasome was blocked. Biologically, this may be of significance since it 354 
was shown that uncleaved IL-1β can be processed in the extracellular space by inflammasome 355 
complexes
38
 or by enzymes such as cathepsin-G and elastase
39
. Consistent with the existence of 356 
an NLRP3-independent death pathway in human macrophages, stable knockdown of NLRP3 in 357 
Page 17 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
 
 17
THP-1 cells blocked nigericin-induced cell death, but only marginally reduced CFT073- and 358 
UTI89-mediated cell death. Whether NLRP3-independent cell death involves activation of 359 
another inflammasome is unknown at this stage. However, given that NLRP3 inhibition ablated 360 
both UPEC-induced IL-1β maturation and caspase-1 cleavage in HMDM, other modes of cell 361 
death such as necroptosis would appear to be more likely. 362 
  363 
Divergence in the repertoire of NLR family members between human and mouse can contribute 364 
to differences in inflammasome responses between these species
10, 40
. However, differences in 365 
the recognition of pathogens by orthologous human and mouse NLRs have also been reported. 366 
For example, F. tularensis activates only the AIM2 inflammasome in mouse macrophages, but 367 
triggers NLRP3- and AIM2-dependent responses in human macrophages
41
. Conversely, L. 368 
monocytogenes was reportedly recognized by AIM2, NLRP3 and NLRC4 in mouse cells
42-44
, but 369 
exclusively by NLRP3 in human cells
45
. The causes for these differences are not fully 370 
understood, but may be related to species differences in ligand recognition. Our study highlights 371 
that one pathogen can activate NLRP3 in both human and mouse macrophages, but through 372 
distinct mechanisms. Our demonstration of α-hemolysin-dependent IL-1β cleavage and cell 373 
death in mouse macrophages is consistent with a recent study showing α-hemolysin-mediated 374 
inflammasome activation in UTI89-infected mice
35
. In stark contrast however, our studies with 375 
human macrophages identified an α-hemolysin-independent pathway to IL-1β maturation. This 376 
suggests that another UPEC factor selectively promotes NLRP3 activation in human but not 377 
mouse macrophages, or that its relative potency in triggering inflammasome responses differs 378 
between these species or between different cell types.  379 
 380 
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Emerging evidence indicates that cytokine processing and pyroptosis can be uncoupled in some 381 
systems. For example, Salmonella-mediated NLRC4 activation promoted IL-1β maturation but 382 
not pyroptosis in mouse neutrophils
46
. Other studies have also reported distinct roles for 383 
individual inflammasomes in cytokine processing versus pyroptosis. For example, NLRP3 was 384 
shown to mediate cell death and IL-1β release in S. aureus-infected HMDM, whilst a novel 385 
NLRP7 inflammasome was shown to selectively promote IL-1β secretion
47
. Similarly, NLRP3 386 
and NLRC4 were shown to mediate B. pseudomallei-induced IL-1β and IL-18 release in the 387 
mouse, whilst pyroptotic cell death was attributed only to NLRC4
48
. At present, there is no 388 
unifying model explaining why similar recognition systems lead to cytokine maturation in one 389 
setting, and pyroptosis in another. Broz et al. proposed that CARD-containing NLRs can initiate 390 
distinct complexes with different roles in mediating cytokine maturation versus pyroptotic cell 391 
death
22
. However, the above described mechanism does not apply for most NLRPs and AIM2, 392 
which contain a pyrin domain rather than a CARD
10
, and does not explain how death and 393 
cytokine responses happen simultaneously in the presence of ASC. The fact that NLRP3 was 394 
causal for cytokine processing but not cell death in human macrophages might again be 395 
interpreted as another example of uncoupling of downstream inflammasome responses. 396 
However, it would seem more likely that the NLRP3-independent cell death pathway overrides 397 
NLRP3-dependent pyroptosis in our system.  398 
 399 
A protective role for inflammasome activation and IL-1β production has been shown in many in 400 
vivo infection models including S. Typhimurium, L. monocytogenesis and Burkholderia species
11
 401 
On the other hand, the role of pathogen-induced cell death is ambiguous, having either protective 402 
or detrimental effects by either eradicating intracellular niches or promoting dissemination, 403 
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respectively
49
. Since UPEC can occupy both extracellular and intracellular niches, it is difficult 404 
to predict what role pyroptosis plays during UTI. Activation of caspase-1/11 was shown to 405 
facilitate clearance of UPEC in a mouse model, presumably by inducing pyroptosis and 406 
subsequent exfoliation of bladder epithelial cells
35
. In another study however, activity of caspase-407 
1/11 was associated with chronicity and higher bacterial loads in the bladder in a model of 408 
recurrent UTI
50
. In the case of cytokine processing, previous studies have associated IL-1β 409 
release with renal pathology of UTI in patients
51, 52
, and also in a mouse model
53
. Only very 410 
recently was IL-1β release in atg16l1-/- mice shown to be associated with protection from UTI
37
. 411 
While the effects of IL-1β can be studied simply by knockout or by blocking its interaction with 412 
receptors, new approaches for genetically and/or pharmacologically uncoupling pyroptosis from 413 
other inflammasome responses will be required to address the role of cell death in pathology. 414 
Whether NLRP3-dependent responses have a causal role in host defence or pathology remains to 415 
be elucidated. 416 
 417 
In conclusion, our study highlights the complexity of interactions between UPEC and the innate 418 
immune system. Some UPEC strains trigger inflammasome activation and rapid, lytic cell death 419 
in macrophages, whereas others, including two strains from the multidrug resistant ST131 420 
lineage, do not. This again highlights the genetic complexity that exists amongst different UPEC 421 
strains and that host response pathways engaged, as well as host colonization strategies 422 
employed, will vary depending on the specific UPEC strain encountered. For inflammasome-423 
activating strains such as CFT073, NLRP3 drives IL-1β maturation in both human and mouse 424 
macrophages. However, this pathway only marginally contributes to cell death in human 425 
macrophages, despite its causal role in cell death in mouse macrophages. Finally, α-hemolysin is 426 
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the primary trigger for cell death and IL-1β release in mouse macrophages, whereas these 427 
cellular responses are either primarily or completely independent of this toxin in human 428 
macrophages. The yet-to-be-identified death pathway in human monocyte-derived macrophages 429 
highlights a potential difference between human and mouse innate immune UPEC recognition 430 
pathways and needs to be considered in future studies using macrophages and other cell types 431 
from a variety of sources, as well as in in vivo studies. Given the importance of mouse UTI 432 
models for understanding host colonization and pathology, and especially in the light of recent 433 
studies showing detrimental and beneficial effects of inflammasome activation in mouse 434 
models
37, 50
, as well as a prominent role for α-hemolysin
35
, our findings are likely to have broad 435 
significance for understanding susceptibility and severity of UTI in humans.   436 
 437 
 438 
 439 
440 
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Methods 441 
 442 
Bacterial strains and growth conditions  443 
UPEC strains CFT073
13
, UTI89
14
, 83972
17
, VR50
18
 and EC958
15
 have been described 444 
previously. MS3179 is an ST131 strain isolated from a patient presenting with UTI at the Royal 445 
Brisbane and Women’s Hospital, Brisbane, Australia. S. Typhimurium strain SL1344
54
 was used 446 
as a control for NLRP3-independent inflammasome activation in some experiments. All strains 447 
were routinely grown at 37˚C on solid or in liquid Luria-Bertani (LB) medium. 448 
 449 
Genetic manipulation procedures and generation of mutants 450 
Mutation of the hlyA, sat and vat genes in CFT073, and the hlyA gene in UTI89, was performed 451 
using the λ-Red recombinase gene replacement system
55
. The primers used for amplification of 452 
the kanamycin resistance gene (hlyA) or chloramphenicol resistance gene (vat, sat), and 453 
subsequent insertion into the chromosome of CFT073 (or UTI89) were as follows: vat (3353: 5’-454 
tcgtaatgaacacagttcatctgatctccacacaccaagacttgataagctcacgtcttgagcgattgtgtagg and 3354: 5’-455 
gaaaccaccaccccatgattttgttttaccgctgtacaggcctgctgacgcgacatgggaattagccatggtcc), sat (3351: 5’-456 
aagaaattccaatgattttgagattcagaggttaaataaatttgttgtggacacgtcttgagcgattgtgtagg and 3352: 5’-457 
ccaggagtgggagctgtagtctctggtgccaaggccggcgaaagttgcggtgacatgggaattagccatggtcc), hlyA (2049: 5’-458 
aaattaaaagcacactacagtctgcaaagcaatcctctgcaaataaattgtgtaggctggagctgcttc and 2050: 5’-459 
tgctctgctgctttttttaatgcatctttcgtgctttgtcctgctgagtgcatatgaatatcctccttag). CFT073 hlyA 460 
(CFT073∆hlyA), sat (CFT073∆sat) and vat (CFT073∆vat) mutants, as well as the UTI89 hlyA 461 
mutant (UTI89∆hlyA), were confirmed by PCR and DNA sequencing. The CFT073hly-sat-vat 462 
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triple mutant was constructed by sequential deletion of each gene, as described above, and was 463 
conﬁrmed by PCR and DNA sequencing.  464 
 465 
Mammalian cell culture  466 
Approval for all experiments using primary human and mouse cells was obtained from the 467 
University of Queensland Medical Research Ethics Committee or the Animal Ethics Committee. 468 
Human monocytes were isolated from buffy coats of healthy donors (kindly provided by the 469 
Australian Red Cross) by positive selection for CD14 using MACS technology (Miltenyi Biotec, 470 
Bergisch Gladbach, Germany), as previously described
56
. HMDM were differentiated for 7 days 471 
with CSF-1 (10,000 U/ml, Chiron Emeryville, CA, USA) from CD14
+
 cells, as previously 472 
described
56
, but in the absence of antibiotics. Cells from a single donor were used in every 473 
experiment. Murine BMM were differentiated using 10,000 U/ml CSF-1 (Chiron) from bone 474 
marrow of C57BL/6 wild type, Nlrp3
-/- 
, Nlrc4
-/-
 , Asc
-/- 
, and Caspase-1/11
-/- 
mice (all described 475 
in
46
), in the absence of antibiotics as previously described
6
. PCC were flushed from the 476 
peritoneal cavity of C57BL/6 mice by injection of 5 ml PBS. THP-1 (TIB-202, ATCC, 477 
Manassas, VA, USA), THP-1 Null and THP-1 defNLRP3 (InvivoGen, San Diego, CA, USA) 478 
cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 1 479 
mM Na-Pyruvate and 10 mM HEPES (all Life Technologies, Carlsbad, CA, USA). THP-1 cells 480 
were differentiated into macrophage-like cells by culture for 48 h in medium containing 30 ng/ml 481 
phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich, St. Louis, MO, USA). PMA or CSF-1 482 
was removed 4 h prior to infection with UPEC strains. Human bladder epithelial cell lines 5637 483 
(HTB-9, ATCC) and T24 (HTB-4, ATCC) were cultured in FBS (10%) and 2 mM L-glutamine 484 
supplemented RPMI-1640 or McCoy’s 5A medium (Life Technologies), respectively.    485 
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 486 
Bacterial culture and macrophage infection assays 487 
UPEC strains were grown statically at 37˚C overnight in LB broth. S. Typhimurium strain 488 
SL1344 was grown overnight in LB broth (200 rpm, 37˚C), diluted 1:33 and grown for another 3 489 
h (to ensure logarithmic growth). Cells were pelleted, washed and adjusted to the same optical 490 
density at 600 nm. A MOI of approximately 10 was used (unless indicated otherwise) and 491 
confirmed by enumeration of colony forming units following serial dilution. Mammalian cells 492 
were seeded at a density of 4-8x10
4
/0.2 ml in 96-well plates or 2-4x10
5
/ml in 24-well plates 493 
(Nunc, Roskilde, Denmark). Medium was changed for all cell types to RPMI-1640 supplemented 494 
with FBS (10%) and 2 mM L-glutamine (all Life Technologies) 4 h prior to infection. LPS-495 
priming was performed by addition of 100 ng/ml Ultrapure LPS from Salmonella minnesota 496 
R595 (InvivoGen). Nigericin sodium salt (Sigma-Aldrich) at a concentration of 10 µM was used 497 
as a positive control for NLRP3-dependent responses. In some experiments, cells were pre-498 
incubated for 1 h with the caspase-1 inhibitor VX-765 (Selleck Chemicals, Houston, TX, USA) 499 
or the NLRP3 inhibitor MCC950
23
, prior to performing infections. At 1 h post-infection, 200 500 
µg/ml gentamicin (Life Technologies) was added for 1 h to inhibit growth of extracellular 501 
bacteria. For infections over a 24 h time course, medium was replaced with fresh medium 502 
containing 20 µg/ml gentamicin for the remaining 22 h. 503 
 504 
Cytotoxicity assays 505 
Cell culture supernatants were collected at 2 or 24 h post-infection, centrifuged for 5 min at 500 506 
g, and analysed for LDH release using the In Vitro Toxicology Assay Kit (Sigma-Aldrich). 507 
Cytotoxicity (%) was calculated by quantification of LDH in culture supernatants versus total 508 
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cellular LDH (present in S/N after cell lysis with 0.1% Triton X-100) according to the formula % 509 
cell death = (100/LDHtotal-LDHspontaneous)x(LDHtreatment-LDHspontaneous). 24 h values represent 510 
summed measurements of the same well at 2 and 24 h post-infection, since medium was changed 511 
at 2 h post-infection as part of the gentamicin exclusion protocol (see: Bacterial culture and 512 
macrophage infection assays).  513 
 514 
Confocal microscopy 515 
Confocal microscopy was performed as previously described
6
. Cells were stained with 200 ng/ml 516 
Alexa Fluor® 594 Phalloidin (Life Technologies) to visualize cell morphology, and ASC was 517 
detected with a rabbit anti-ASC Antibody (N-15)-R (Santa Cruz Biotechnology, Santa Cruz, CA) 518 
(1:300) and Alexa Fluor® 647 or 688-conjugated chicken anti-Rabbit IgG (Life Technologies) as 519 
a secondary antibody (1:150). For quantifying ASC speck formation, HMDM were cultured in 520 
12 mM glycine to reduce loss of cells due to lytic cell death
57
. ASC specks were counted 521 
manually in a blinded fashion (5 fields at 40x magnification per condition per replicate). 522 
 523 
Immunoblotting 524 
4x10
5 
cells were lysed in 100 µl 2xSDS loading buffer (125 mM Tris-HCl, 20% glycerol (v/v), 525 
4% SDS (w/v), pH 6.8). For analysis of secreted caspase-1 in cell culture supernatants, medium 526 
was replaced with OptiMEM medium (Life Technologies) 4 h prior to infection. Cell culture 527 
supernatants were precipitated by incubation with 4 volumes of acetone at -20˚C overnight and 528 
centrifugation at 5300 g and -10˚C for 30 min. Pellets were taken up in 2xSDS loading buffer. 529 
Western blotting was performed as previously described
56
. Membranes were stained with 530 
cleaved IL-1β (Asp116) rabbit mAb, IL-1β (3A6) mouse mAb, cleaved caspase-1 (ASP297) 531 
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(D57A2) rabbit mAb (all Cell Signalling Technology, Danvers, MA, USA), mouse IL-1β/IL-1F2 532 
affinity purified polyclonal Ab, Goat IgG (R&D Systems, Minneapolis, MN, USA), anti-533 
caspase-1 (p20) (mouse) mAb (Adipogen, San Diego, CA, USA), anti-NLRP3/NALP3 mAb 534 
(Cryo-2) (Adipogen) or human anti-G3PDH antibody (Trevigen, Gaithersburg, MD, USA). All 535 
primary antibodies were diluted 1:1000 except for human anti-G3PDH antibody, which was used 536 
at 1:10000. As secondary antibodies, anti-mouse and anti-rabbit IgG, HRP-linked Antibodies 537 
(Cell Signalling Technology) (1:2500) and anti-goat IgG-peroxidase antibody (Sigma-Aldrich) 538 
(1:5000) were used. HRP was detected using ECL Plus substrate (GE Healthcare, 539 
Buckinghamshire, UK) and Super RX film (Fujifilm, Tokyo, Japan).  540 
 541 
ELISA 542 
Cell culture supernatants were analysed for IL-1β with the human or mouse IL-1β/IL-1F2 543 
DuoSet ELISA kit (R&D Systems) (detection limit 4 and 15.6 pg/ml, respectively) and anti-544 
human or mouse ELISA Ready-Set-Go! (eBiosciece, San Diego, CA, USA) (detection limit: 4 545 
and 8 pg/ml, respectively). TNF-α was detected using the Mouse TNF OptEIA ELISA set (BD 546 
Biosciences, San Diego, CA, USA) (detection limit: 15.6 pg/ml) and the human TNF-α standard 547 
ELISA Developmental kit (Peprotech, Rocky Hill, NJ, USA) (detection limit: 16 pg/ml) .  548 
 549 
Statistical Analysis 550 
All LDH, ELISA and MTT assays were performed using duplicate or triplicate cell culture wells 551 
for individual experiments. Presented data are typically mean values combined from three or 552 
more independent experiments, unless otherwise indicated. For statistical analysis of datasets 553 
with N>4, two-sided Wilcoxon matched-pairs signed-rank tests were performed using GraphPad 554 
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Prism Version 6 (GraphPad software, Inc., La Jolla, CA, USA). For these datasets, the 555 
differences between pairs were plotted and were generally distributed approximately 556 
symmetrically around the median.  557 
558 
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 804 
Figure legends 805 
 806 
Figure 1: The UPEC strains CFT073 and UTI89 induce rapid cell death in macrophages. 807 
A-C) HMDM or BMM were infected with the indicated UPEC strains (MOI 1, 10 and 100). 808 
Supernatants were analyzed by LDH release assays at the indicated times post-infection (p.i.). 809 
Data represent the mean+SEM of three independent experiments. D) Human macrophage-like 810 
cells (THP-1) and mouse peritoneal cavity cells (PCC), as well as human T24 and 5637 bladder 811 
epithelial cells, were infected with the indicated UPEC strains (MOI 10) for 2 h. Supernatants 812 
were analyzed by LDH release assay. Data represent the mean+range of two independent 813 
experiments. 814 
 815 
Figure 2: The UPEC strains CFT073 and UTI89 promote IL-1β secretion, caspase-1 816 
cleavage and ASC-speck formation. A) HMDM and BMM were primed with 100 ng/ml LPS 817 
for 4 h, then infected with the indicated UPEC strains (MOI 10) for 2 h. Supernatants were 818 
analyzed by ELISA. Data represent the mean+SEM of three independent experiments. B) 819 
HMDM and BMM were infected with the indicated UPEC strains for 1 h. Whole cell lysates and 820 
concentrated supernatants were analyzed by western blot with antibodies detecting human or 821 
mouse caspase-1 p20. GAPDH is shown as a loading control. Similar findings were apparent in 822 
three independent experiments. C) HMDM were infected with the indicated UPEC strains (MOI 823 
10) for 2 h, after which they were fixed and analyzed by confocal microscopy. Arrowheads 824 
indicate ASC-specks. Similar results were apparent in two independent experiments. 825 
 826 
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Figure 3: In murine macrophages, CFT073-induced caspase-1 cleavage and cell death is 827 
dependent on the NLRP3 inflammasome. BMM derived from wild type, Nlrp3-, Nlrc4-, Asc- 828 
and Casp1/11-deficient mice were infected with the UPEC strain CFT073 or the S. Typhimurium 829 
strain SL1344 (MOI 10), or were stimulated with nigericin (10 µM, pre-stimulated with 100 830 
ng/ml LPS for 4 h). A) After 1 h, whole cell lysates and concentrated supernatants were analyzed 831 
by western blot with antibodies detecting murine full-length caspase-1, as well as multiple 832 
caspase-1 cleavage products. GAPDH was used as loading control. Data is representative of two 833 
independent experiments. B) Supernatants were analyzed by LDH assay at 2 h p.i. Data is the 834 
mean+range of two independent experiments. C) LPS-primed BMM (100 ng/ml, 4 h) were 835 
treated as above, after which secreted IL-1β was measured by ELISA after 2 h. Data are 836 
mean+SEM of three independent experiments. 837 
 838 
Figure 4: NLRP3 contributes to IL-1β release and maturation but does not mediate cell 839 
death in human macrophages responding to CFT073. A-B) HMDM were primed with LPS 840 
(100 ng/ml, 4 h) or left untreated, then pretreated for 1 h with the NLRP3 inhibitor MCC950 (10 841 
µM) and subsequently infected with the UPEC strain CFT073 or S. Typhimurium SL1344 (MOI 842 
10), or stimulated with nigericin (10 µM). Supernatants were collected at 2 h p.i., and analyzed 843 
by LDH release assay (A) and ELISA (B). Data are from nine (CFT073, LPS/nigericin) and six 844 
(S. Typhimurium) independent experiments (different donors), respectively. Statistical analysis 845 
was performed using a Wilcoxon matched-pairs signed-rank tests: ns: p> 0.05, *: p<=0.05, **: 846 
p<=0.01. C) Concentrated supernatants from cells treated as described above were analyzed by 847 
western blot with antibodies detecting full-length or cleaved human IL-1β. D) HMDM were 848 
treated as above, but in presence of 12 mM glycine, and analyzed by confocal microscopy. ASC 849 
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specks and nuclei were counted manually in a blinded manner. Data are mean+SEM of three 850 
independent experiments. 851 
 852 
Figure 5: UPEC-mediated cell death is blocked by caspase-1 inhibition in mouse but not 853 
human macrophages. A-B) HMDM and BMM were primed with LPS (100 ng/ml, 4 h) or left 854 
untreated, then pretreated for 1 h with the caspase-1 inhibitor VX-765 (50 µM), and 855 
subsequently infected with the UPEC strain CFT073 (MOI 10) or stimulated with nigericin (10 856 
µM). Supernatants were collected at 2 h p.i., and were analyzed for cell death by LDH release 857 
assay (A) and IL-1β release by ELISA (B). Data represent the mean+SEM of three independent 858 
experiments. (C-D) HMDM and BMM were treated as above for 1 h. Cell lysates, as well as cell 859 
culture supernatants, were analyzed by western blot for cleavage of caspase-1. GAPDH served as 860 
loading control. Similar results were obtained in two independent experiments. 861 
 862 
Figure 6: UPEC triggers NLRP3-independent cell death in human macrophages. Stable 863 
NLRP3 knockdown THP-1 cells (defNLRP3), as well as THP-1 control cells (Null) were 864 
infected with the indicated UPEC strains or S. Typhimurium (MOI 10), or were treated with 865 
nigericin (10 µM) for 1 h (A) or 2 h (B). A) Cell lysates were analyzed by western blot for 866 
expression of NLRP3 and GAPDH as a loading control. Caspase-1 p20 was detected in cell 867 
lysates. Similar findings were apparent in two independent experiments. B) Supernatants of 868 
unprimed or LPS primed (100 ng/ml LPS, 4 h) THP-1 cells were analyzed by LDH assay. Data 869 
are the mean+SEM of four independent experiments.  870 
 871 
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Figure 7: Differences between human and mouse macrophages in cellular responses to α-872 
hemolysin. A-B) HMDM and BMM were infected with wild type UPEC strains or mutants 873 
deficient for α-hemolysin  (∆hlyA), sat (∆sat), vat (∆vat) or all three genes (∆hlyA;∆sat;∆vat) at 874 
the indicated MOI for 2 h. Supernatants were analyzed by LDH assay. C) LPS–primed (100 875 
ng/ml, 4 h) cells were treated as above (MOI 10) and analyzed by IL-1β ELISA. Data are the 876 
mean+SEM of three (A, C) or four (B) independent experiments. D) Concentrated supernatants 877 
from cells treated as described above were analyzed by western blot with antibodies detecting 878 
cleaved human or mouse IL-1β. Similar observations were made in 2 independent experiments. 879 
 880 
Page 37 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
  
 
 
Fig. 1  
122x89mm (300 x 300 DPI)  
 
 
Page 38 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
  
 
 
Fig. 2  
208x289mm (300 x 300 DPI)  
 
 
Page 39 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
  
 
 
Fig. 3  
141x113mm (300 x 300 DPI)  
 
 
Page 40 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
  
 
 
Fig. 4  
131x134mm (300 x 300 DPI)  
 
 
Page 41 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
  
 
 
Fig. 5  
136x112mm (300 x 300 DPI)  
 
 
Page 42 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
  
 
 
Fig. 6  
70x29mm (300 x 300 DPI)  
 
 
Page 43 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
  
 
 
Fig. 7  
158x141mm (300 x 300 DPI)  
 
 
Page 44 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
Supplementary Figures 
 
  
Figure S1: UPEC strains CFT073 and UTI89 induce cell death in epithelial cells at high MOI. Human bladder epithelial cell lines (T24 and 5637) were infected with the 
indicated UPEC strains (MOI 1000) for 24 h. Supernatants were analyzed by LDH release assay. Data are the mean + range of two independent experiments. 
 
Figure S2: TNF-α secretion inversely correlates with cell death in HMDM, whilst IL-1β secretion correlates with cell death in all cell types examined. A) HMDM and 
BMM were infected with the indicated UPEC strains (MOI 10) for 2 h and supernatants were analyzed by ELISA. B) THP-1, T24 and 5637 cells and C) mouse peritoneal cavity 
cells (PCC) were primed with 100 ng/ml LPS for 4 h, then infected with the indicated UPEC strains for 2 h (MOI 10) or stimulated with nigericin (10 µM) for 2 h. Supernatants 
were analyzed by ELISA. Data in A-C are the mean + SEM of three independent experiments. 
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Figure S3: NLRP3 inhibition has differing effects in CFT073-infected primary human versus mouse macrophages. HMDM and BMM were primed with LPS (100 ng/ml, 4 
h) or were left untreated, then pretreated for 1 h with the NLRP3 inhibitor MCC950 (10 µM), and subsequently infected with the UPEC strain CFT073 (MOI 10) or stimulated 
with nigericin (10 µM). At 2 h p.i., supernatants were collected and analyzed by A) LDH release assay and B) IL-1β ELISA. Data are the mean + SEM of three independent 
experiments. 
 
Figure S4: CFT073- and UTI89-triggered cell death is mediated by a large, soluble factor(s) that is heat- and protease-sensitive. A) PMA-differentiated THP-1 cells were 
treated with live bacteria at MOI 10, heat inactivated supernatants and bacteria (95˚C, 20 min) (HI bacteria), 10% filtered (0.45 µm) supernatants from bacterial overnight cultures 
(S/N), or flow though from filtration with Amicon Ultra-15 centrifugal fiter units with 30 kDa cutoff (S/N < 30 kDa). Cell culture supernatants were analyzed by LDH release 
assay after 2 h. Similar results were obtained in two independent experiments. B) PMA-differentiated THP-1 cells were treated with bacterial culture supernatants as above (S/N) 
or supernatants pretreated with proteinase K (100 µg/ml) for 45 min at 37˚C (S/N +Prot K). Cell viability was assessed by methylthiazolyldiphenyl-tetrazolium bromide (MTT) 
viability assays. Medium was replaced with medium containing 1 mg/ml MTT (Sigma-Aldrich) 2 h post-infection and incubated at 37˚C and 5% CO2 for another 2 h. Cells were 
lysed in isopropanol and formation of formazan was assessed by measuring absorption at 570 nm. Cell viability was calculated as % of absorption at 570 nm of untreated cells. 
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Donor : 1 2 3 4 5 6 7 8 9
MCC950 Average
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
+ 0.34 0.47 1.21 2.83 -0.23 -1.16 0.00 0.00 0.00 0.38
- 6.93 34.49 27.71 39.05 8.08 63.04 17.32 23.25 35.83 28.41
+ 0.51 25.89 24.66 29.14 1.18 62.69 21.88 25.61 32.43 24.89
- 46.68 14.72 18.63 24.28 14.73 18.89 4.60 7.91 26.25 19.63
+ 1.06 14.98 16.85 3.19 1.89 2.63 -0.45 0.50 -1.54 4.35
- 10.71 49.15 32.57 27.43 17.73 48.54 ND ND ND 31.02
+ 10.95 43.51 45.27 27.51 20.24 61.45 ND ND ND 34.82
- 24.82 30.66 29.16 33.79 ND ND ND ND ND 29.61
+ -0.01 22.72 24.66 20.15 ND ND ND ND ND 16.88
Donor : 1 2 3 4 5 6 7 8 9
MCC950 Average
- 41.74 42.49 37.23 15.48 43.21 12.56 0.00 25.94 0.00 24.29
+ 41.89 42.49 49.64 26.26 117.92 7.00 2.73 8.93 0.00 32.98
- 1877.28 232.20 2973.51 1084.81 2973.85 9706.29 685.04 2259.10 2876.68 2740.97
+ 363.65 67.74 1803.38 149.82 117.58 1093.71 501.10 1527.51 1539.38 795.98
- 1314.92 107.99 4872.90 1202.30 4629.54 5147.09 1497.69 2994.72 1949.71 2635.21
+ 46.94 43.10 74.98 44.01 106.71 33.27 3.47 27.50 0.00 42.22
- 5215.72 2708.92 7228.57 4618.81 3074.61 10308.71 ND ND ND 5525.89
+ 5701.27 2718.58 3973.76 4733.99 4182.30 6127.35 ND ND ND 4572.87
- 2235.10 238.90 4034.61 1220.35 ND ND ND ND ND 1932.24
+ 155.28 57.51 336.57 147.63 ND ND ND ND ND 174.25
% Cell death
LPS+UTI89
IL-1β [pg/ml]
LPS
LPS+CFT073
LPS+Nig
LPS+Sal
LPS+UTI89
LPS
LPS+CFT073
LPS+Nig
LPS+Sal
Table S1: NLRP3 contributes to IL-1b release but contributes only marginally to cell death in human macrophages responding to the UPEC strains CFT073 and UTI89. HMDM 
were primed with LPS (100 ng/ml, 4 h), pretreated for 1 h with the NLRP3 inhibitor MCC950 (10 mM) and then subsequently infected with the UPEC strains CFT073 or UTI89 
or S. Typhimurium SL1344 (MOI 10), or were stimulated with nigericin (10 mM). Supernatants were collected at 2 h p.i., and analyzed by LDH release assay and ELISA. Data 
are from nine (CFT073, LPS/nigericin), six (S. Typhimurium) or four (UTI89) independent experiments (different donors), respectively. ND = not determined. 
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Abstract 26 
Uropathogenic E. coli (UPEC) is the main etiological agent of urinary tract infections (UTI). 27 
Little is known of theabout interactions between UPEC and the inflammasome, a key innate 28 
immune pathway. Here we show that UPEC strains CFT073 and UTI89 trigger inflammasome 29 
activation and lytic cell death in human macrophages. Several other UPEC strains, including 30 
globally disseminatedtwo multidrug resistant ST131 lineage isolates, did not kill macrophages. 31 
In mouse macrophages, UTI89 triggered cell death only at a high MOI, and CFT073-mediated 32 
inflammasome responses were completely NLRP3-dependent. Surprisingly, CFT073- and 33 
UTI89-mediated responses only partially depended on NLRP3 in human macrophages. In these 34 
cells, NLRP3 contributed towas required for IL-1β maturation, andbut contributed only 35 
marginally to cell death. Similarly, caspase-1 inhibition did not block cell death in human 36 
macrophages. In keeping with such differences, the pore forming toxin α-hemolysin mediated a 37 
substantial proportion of CFT073-triggered IL-1β secretion in mouse but not human 38 
macrophages. Moreover, thereThere was also a more substantial α-hemolysin-independent cell 39 
death response in human versus mouse macrophages. Thus, in mouse macrophages, CFT073-40 
triggered inflammasome responses are completely NLRP3-dependent, and largely α-hemolysin-41 
dependent. In contrast, UPEC activates an NLRP3-independent cell death pathway and an α-42 
hemolysin-independent IL-1β secretion pathway in human macrophages. This has important 43 
implications for understanding UTI in humans.  44 
 45 
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Introduction 49 
Uropathogenic Escherichia coli (UPEC) is estimated to cause up to 7580% of community-50 
acquired and 65% of nosocomial urinary tract infections (UTI), making it the single most 51 
important etiological agent of this highly prevalent infectious disease
1
. UTI typically involves 52 
infection of the bladder (cystitis) or kidneys (pyelonephritis), and can also lead to renal scarring 53 
and sepsis1, 21, 2. Asymptomatic bacteriuria (ABU), caused by various etiologic agents, is also 54 
common
3
.  55 
 56 
Mouse UTI models, as well as genetic associations within patient cohort studies, have helped to 57 
pinpoint the roles of specific innate immune pathways in defense against uropathogens
2
. Such 58 
studies have highlighted the importance of members of the Toll-like Receptor family in 59 
controlling bacterial growth and dissemination, as well as causing symptoms and pathology. At 60 
the cellular level, roles of the urothelium and neutrophils in innate defence and host subversion 61 
during UTI are well established. However, surprisingly little is known about the roles of 62 
monocytes and macrophages in these processes
4
. A recent study by Schiwon et al. dissected the 63 
role of different macrophage populations in a mouse UTI model and unraveled complex 64 
interactions of sentinel and helper macrophages governing antimicrobial actions of neutrophils5. 65 
We previously demonstrated that some UPEC strains can survive for up to 24 h in murine bone 66 
marrow-derived macrophages (BMM) within LAMP1
+
 compartments
6
, reminiscent of quiescent 67 
intracellular reservoirs observed in epithelial cells that may facilitate recurrent infection. Thus, 68 
the role of myeloid cells in UPEC infection may not always be protective. 69 
 70 
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 5
Upon detection of cellular stress and/or microbial products, some Nod-like-receptor (NLR) 71 
family members, as well as the PYHIN-family member AIM2, form large cytoplasmic 72 
multiprotein complexes known as inflammasomes. Inflammasomes have important functions in 73 
many bacterial infections
7
, as well as in chronic diseases
8, 98, 9
. The NLR-family comprises 74 
twenty-two genes in humans and more than thirty in mice, and can be phylogenetically grouped 75 
into the NLRP, IPAF and NOD sub-families
10
. The NLRP family members NLRP1 and NLRP3, 76 
as well as the IPAF family member NLRC4, can all initiate inflammasome formation. Most 77 
NLRP family members contain a C-te minal leucine rich repeat that is involved in danger 78 
sensing, a central nucleotide-binding and oligomerisation domain, and an N-terminal pyrin 79 
domain that relays downstream signalling. NLRC4 has a similar domain structure, but contains 80 
an N-terminal caspase recruitment domain (CARD), rather than a pyrin domain. Upon activation, 81 
NLRPs oligomerise and cluster into a cytoplasmic complex with the adapter protein ASC and the 82 
protease caspase-1, facilitating its autocatalytic cleavage and activation. Active caspase-1 is 83 
required for maturation and secretion of the pro-inflammatory IL-1 family cytokines, IL-1β and 84 
IL-18. One of the many functions of IL-1β is to facilitate neutrophil and macrophage recruitment 85 
to sites of infection. In addition to mediating cytokine processing, inflammasome activation also 86 
initiates a programmed, pro-inflammatory form of cell death called pyroptosis. Pyroptotic cell 87 
death is thought to eliminate the intracellular replication niche of pathogens that infect 88 
macrophages (e.g. Shigella, Salmonella, Legionella and Listeria) and to re-expose them to 89 
antimicrobial effector functions
7, 117, 11
.  90 
 91 
Among the different pathogenic E. coli subtypes, enterohemorrhagic E. coli O157:H7, which 92 
causes severe enteritis, triggers inflammasome activation12. However, until very recently no 93 
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studies havehad investigated inflammasome involvement in UPEC recognition or UTI. In this 94 
study, we show that the genome-sequenced UPEC reference strains CFT073 and UTI89 trigger 95 
inflammasome activation and rapid cell death in macrophages, whereas others do not. Moreover, 96 
we define key mechanistic differences between human and mouse macrophages in the host 97 
recognition pathways and bacterial factors that initiate these responses. Our findings of 98 
fundamental differences between different UPEC strains in inflammasome engagement, as well 99 
as between human and mouse innate immune recognition pathways for UPEC, have major 100 
implications for understanding and modeling UTI pathogenesis. 101 
 102 
 103 
 104 
 105 
 106 
 107 
 108 
 109 
 110 
 111 
 112 
 113 
 114 
 115 
 116 
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 118 
Results 119 
 120 
UPEC strains CFT073 and UTI89 cause rapid cell death in macrophages 121 
Given the paucity of information on interactions between UPEC and macrophages, we 122 
investigated whether the survival of human monocyte-derived macrophages (HMDM) was 123 
affected by different UPEC strains. We analyzed strains associated with different UTI severity, 124 
including the reference strains CFT073 (a blood culture isolate from a patient with pyelonephritis 125 
isolate)
13
 and UTI89 (a urine isolate from a patient with recurrent cystitis isolate)
14
, the 126 
ST131sequence type (ST) 131 strains EC95815, 1615, 16 and  MS3179 (urine isolates from patients 127 
with UTI) and the asymptomatic bacteriuria (ABU) strains 83972 and VR50
17, 1817, 18
. These 128 
experiments revealed that only CFT073 and UTI89 caused rapid, lytic cell death by 2 h post-129 
infection as assessed by LDH release (Fig. 1A). Cell death was further increased by 24 h post-130 
infection (Fig. 1B). A direct comparison of HMDM with murine BMM over a multiplicity of 131 
infection (MOI) range confirmed that mouse macrophages were also similarly susceptible to 132 
CFT073-induced cell death (Fig. 1C). In BMM, UTI89 did not trigger cell death, except at the 133 
highest MOI used (MOI 100, Fig. 1C). This is consistent with our previous findings that UTI89 134 
can survive for up to 24 h within BMM6, 196, 19. To investigate whether UPEC-mediated cell 135 
death is a macrophage-specific phenomenon, the response to CFT073, UTI89 and MS3179 was 136 
also analyzed in PMA-differentiated THP-1 cells (a human macrophage-like cell line), murine 137 
peritoneal cavity cells (PCC, which are predominantly comprised of resident peritoneal 138 
macrophages
20
) and two human bladder epithelial cell lines (5637 and T24) commonly used to 139 
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study UPEC infection in vitro (Fig. 1D). PMA-differentiated THP-1 cells showed a similar 140 
response to HMDM. CFT073 also triggered cell death in PCC, whereas the effect of UTI89 was 141 
much weaker, similar to the findings with mouse BMM (compare Fig. 1C). The ST131 isolate 142 
MS3179 did not trigger cell death in any of the cell types tested, and the two epithelial cell lines 143 
were not killed efficiently by any of the UPEC strains at an MOI of 10 at 2 h post-infection (Fig. 144 
1D). However, 24 h exposure of epithelial cell lines to a very high MOI (MOI 1000) of all UPEC 145 
strains did result in some cell death (Fig. S1). Collectively, these data demonstrate substantial 146 
variability in the capacity of different UPEC strains to elicit macrophage cell death. 147 
 148 
UPEC-mediated macrophage cell death correlates with inflammasome activation 149 
To investigate potential involvement of the inflammasome pathway in cell death, we first 150 
examined the capacity of UPEC strains to trigger IL-1β release from LPS-primed macrophages. 151 
LPS priming was performed to boost pro-IL-1β levels, allowing the use of IL-1β release as a 152 
marker for inflammasome activation with minimal interference by rapid cell death. or by other 153 
confounding processes such as suppression of cytokine production by some UPEC strains21. 154 
Indeed, we found that, whereas CFT073, UTI89 and MS3179 all elicited similar levels of 155 
secreted TNF-α from BMM, this response was greatly reduced in HMDM infected with strains 156 
triggering rapid cell death (CFT073, UTI89) as compared to MS3179 that did not cause cell 157 
death (Fig. S2A). Thus, TNF-α release inversely correlated with UPEC-induced rapid cell death 158 
in HMDM, as might be expected given that this cytokine must be synthesized prior to its release. 159 
In the case of IL-1β release correlatedfrom LPS-primed cells that already express pro-IL-1β, 160 
there was a clear correlation with induction of cell death in all cases. In human macrophages 161 
(HMDM and PMA-differentiated THP-1 cells), both CFT073 and UTI89 (MOI 10) triggered IL-162 
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1β release (Fig. 2A and S2AS2B). In contrast, CFT073 but not UTI89 (MOI 10) elicited IL-1β 163 
release from LPS-primed mouse macrophages (BMM and PCC) (Fig. 2A and S2BS2C), 164 
consistent with the failure of UTI89 to trigger robust cell death in mouse macrophages at low 165 
MOI (compare Fig. 1C and 1D). Also consistent with the cell death data, the ST131 strain 166 
MS3179 did not trigger IL-1β release from LPS-primed macrophages of either human or murine 167 
origin. LPS-primed epithelial cell lines did not release IL-1β in response to any of the UPEC 168 
strains tested (Fig. S2AS2B). Similar patterns were observed for caspase-1 cleavage; both 169 
CFT073 and UTI89 triggered comparable capase-1 cleavage in human macrophages (Fig. 2B), 170 
whilst in mouse macrophages the response forto CFT073 was much more pronounced than for 171 
UTI89 (Fig. 2B). Another hallmark of inflammasome activation, the formation of ASC specks, 172 
was also apparent in CFT073- and UTI89-infected human macrophages, whereas the ST131 173 
strain MS3179 did not elicit this effect (Fig. 2C). AdditionallyFurthermore, infection with the 174 
two ASC speck-inducing UPEC strains (i.e. CFT073 and UTI89) ledappeared to dramaticinduce 175 
morphological changes and loss of nuclear integrity in HMDM, as visualized by actin and DNA 176 
staining. in the same samples (Fig. 2C).   177 
 178 
CFT073-mediated cell death in murine macrophages is completely dependent on the 179 
NLRP3 inflammasome  180 
Causality of inflammasome activation and cell death in BMM was analysed using macrophages 181 
deficient for NLRP3 and NLRC4 (two NLRs most commonly activated by bacterial infection
7
), 182 
the inflammasome adaptor protein ASC, or the inflammatory caspases, caspase-1 and -11. Since 183 
UTI89 did not trigger pronounced inflammasome activation in mouse macrophages at an MOI of 184 
10, only CFT073 was assessed. CFT073-mediated caspase-1 cleavage was completely dependent 185 
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on NLRP3 and ASC, but did not require NLRC4 (Fig. 3A). As expected, the positive controls 186 
nigericin and Salmonella enterica serovar Typhimurium (S. Typhimurium) strain SL1344 acted 187 
via NLRP3 and NLRC4, respectively (Fig. 3A). Analysis of LDH release confirmed that 188 
NLRP3, ASC and Caspase-1/11 were required for CFT073-mediated cell death (Fig. 3B). These 189 
inflammasome components were also indispensable for CFT073-triggered IL-1β release from 190 
LPS-primed BMM (Fig. 3C). As with caspase-1 cleavage, NLRC4-deficiency did not affect 191 
LDH or IL-1β release upon infection with CFT073. Again, the positive controls for NLRP3, 192 
ASC and caspase-1 involvement (nigericin), and NLRC4 and caspase-1 involvement (S. 193 
Typhimurium), behaved as expected. ASC was dispensable for S. Typhimurium-mediated cell 194 
death (Fig. 3B) as previously reported2122, and NLRP3, ASC and caspase-1/11 were 195 
indispensable for nigericin-triggered IL-1β release (Fig. 3C). S. Typhimurium-triggered IL-1β 196 
release was partially dependent on NLRP3 and ASC, and completely dependent on NLRC4 and 197 
caspase-1/11. Hence, rapid cell death and IL-1β secretion triggered by CFT073 in mouse 198 
macrophages is dependent on NLRP3, ASC and caspase-1 and/or -11.  199 
 200 
In human macrophages, UPEC-mediated IL-1β secretion is partially dependent on NLRP3, 201 
whereas cell death is primarily NLRP3-independent 202 
We next investigated NLRP3 involvement in human macrophage responses to UPEC, using a 203 
recently described NLRP3 inhibitor, MCC950
22
. using MCC950, a recently described NLRP3 204 
inhibitor that does not affect AIM2, NLRP1 or NLRC4-mediated inflammasome activation23. 205 
Surprisingly, in LPS-primed HMDM, MCC950 blocked nigericin-triggered cell death, but had 206 
little effect on CFT073-triggered cell death in cells from most donors examined (Fig. 4A, Table 207 
S1). In contrast, MCC950 significantly reduced both nigericin- and CFT073-triggered IL-1β 208 
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release from LPS-primed HMDM (Fig. 4B). Similar observations were apparent for UTI89, 209 
where MCC950 had only modest effects in reducing UTI89-triggered cell death for HMDM 210 
from 3 out of 4 donors (Table S1). This suggests that there are differences between human and 211 
mouse macrophages in NLRP3 responses to UPEC. Indeed, a direct comparison revealed that, 212 
whereas MCC950 completely inhibited responses to nigericin in both HMDM and BMM, 213 
CFT073-mediated cell death was only blocked in mouse macrophages (Fig. S3A). Moreover, 214 
LPS priming had no apparent effect on NLRP3-dependency of CFT073-mediated cell death in 215 
human or mouse macrophages. In contrast to differential effects on cell death, MCC950 inhibited 216 
CFT073-triggered IL-1β release in both LPS-primed HMDM and BMM, albeit more effectively 217 
in BMM (Fig. S3B). The level of NLRP3-dependence for CFT073-triggered IL-1β release varied 218 
between cells from different donors (Fig. 4B, S3BTable S1), and MCC950 never completely 219 
abolished IL-1β release, as was the case for nigericin. ThisWe therefore suggests that CFT073 220 
triggers both NLRP3-dependent and -independent inflammasomes in human macrophages. To 221 
examine thisinvestigated the possibility that the residual IL-1β response detected by ELISA 222 
might be due to the release of unprocessed IL-1β, as a consequence of cell death. Indeed, 223 
analysis of concentrated cell culture supernatants by immunoblotting revealed that treatment 224 
with MCC950 completely blocked release of mature IL-1β from CFT073-infected HMDM, 225 
whereas pro-IL-1β was still present in culture supernatants (Fig. 4C). , weWe also monitored 226 
ASC speck formation upon NLRP3 inhibition in HMDM. In these experiments, the NLRP3 227 
inhibitor MCC950 completely blocked nigericin- but not S. Typhimurium-triggered ASC speck 228 
formation (Fig. 4D).4C). In contrast to its effects on the nigericin response, MCC950 229 
substantially reduced, but did not ablate, CFT073- and UTI89-induced ASC speck formation in 230 
all experiments. (Fig. 4D). 231 
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 232 
To further investigate inflammasome involvement in human macrophages, the effect of the 233 
caspase-1 specific inhibitor VX-765
2324
 on CFT073-triggered cell death in human and mouse 234 
macrophages was examined. VX-765 effectively blocked CFT073- and LPS/nigericin-triggered 235 
cell death and IL-1β release by LPS-primed BMM at 2 h post-infection (Fig. 5A-B). However, 236 
similar to the observations with MCC950, VX-765 reduced CFT073-mediated IL-1β release 237 
from LPS-primed HMDM, but did not affect cell death. Control experiments confirmed that both 238 
inhibitors blocked cleavage and release of caspase-1 in response to CFT073 infection and 239 
LPS/nigericin stimulation in HMDM and BMM (Fig. 5C-D). Together, these findings indicate 240 
that (1) the NLRP3 inflammasome primarily drives UPEC-triggered IL-1β maturation in human 241 
macrophages; (2) another inflammasome also likely contributes to this response; and (32) an 242 
NLRP3-independent pathway is the primary mediator of UPEC-triggered cell death in human 243 
macrophages.  244 
 245 
To independently verify that an NLRP3-independent pathway mediates UPEC-triggered cell 246 
death, we used THP-1 defNLRP3 cells, which stably express an NLRP3 shRNA and have 247 
reduced NLRP3 expression compared to a control cell line (THP-1 Null) transfected with an 248 
‘empty’ construct (Fig. 6A). Caspase-1 processing in THP-1 defNLRP3 cells responding to 249 
CFT073, UTI89 or LPS/nigericin was greatly reduced, whereas caspase-1 p20 was still 250 
detectable at high levels after infection with S. Typhimurium. In these cells, CFT073 and UTI89 251 
still triggered substantial cell death, whereas LPS/nigericin did not (Fig. 6B). Again, LPS 252 
priming had no effect on the degree of NLRP3 dependency of UPEC-mediated cell death., 253 
although it did appear to reduce the effect of NLRP3-knockdown in the nigericin control. As 254 
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expected, no reduction in cell death was observed in defNLRP3 cells when using S. 255 
Typhimurium as an NLRP3-independent trigger for cell death. Collectively, these data suggest 256 
the involvement of another NLRP3-independent, cell death pathway triggered by UPEC. 257 
 258 
α-hemolysin is the main factor in CFT073 triggering cell death and IL-1β release in mouse 259 
but not human macrophages 260 
The capacity for CFT073 and UTI89 to trigger human macrophage cell death was also conferred 261 
by culture supernatants (Fig. S4). Crude biochemical analysis indicated that the factor(s) 262 
responsible were heat- and protease-sensitive, and with a likely molecular weight of greater than 263 
30 kDa. Candidate proteins mediating cell death and/or IL-1β secretion included the pore 264 
forming toxin α-hemolysin, as well as serine-protease autotransporter toxins (Sat and Vat). 265 
Genes encoding all three toxins are present in CFT073, while UTI89 contains the hlyCABD (α-266 
hemolysin operon) and vat genes. To test the involvement of these three toxins in triggering the 267 
inflammasome response, we generated a series of CFT073 mutants deleted for genes encoding 268 
each individual toxin and a triple-mutant deficient in the ability to produce all three toxins. 269 
Compared to wild type CFT073, the α-hemolysin (hlyA) mutant (CFT073∆hlyA) was greatly 270 
impaired in its ability to trigger cell death of mouse macrophages (-70%)(~30% of wild type) 271 
and, to a lesser extent, of human macrophages (-40%)(~60% of wild type) when macrophages 272 
were exposed to an MOI of 10 (Fig. 7A). CFT073 sat- and vat- mutants were very modestly 273 
compromised for their ability to trigger mouse and human macrophage cell death. However, no 274 
additive effect was observed, as the triple-mutant showed no difference to the CFT073∆hlyA 275 
single mutant in this assay. Similar observations were made at an MOI of 100 with both CFT073 276 
and UTI89 (Fig. 7B).hlyA single-mutant in this assay. Intriguingly, analysis of IL-1β secretion In 277 
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this case, cell death induced by CFT073 and UTI89 was almost completely hlyA-independent in 278 
HMDM (cell death for hlyA mutants was ~85% of the wild type strains), whereas in BMM the 279 
response was largely hlyA-dependent (~30% and 40% of wild type strains). Intriguingly, analysis 280 
of IL-1β release revealed a striking difference between human and mouse macrophages with 281 
respect to triggering by α-hemolysin. Whereas IL-1β levels were substantially reduced in BMM 282 
responding to the hlyA-mutant asCFT073∆hlyA compared to wild type CFT073, deletion of hlyA 283 
had no effect on HMDM responses (Fig. 7C). Again, we analysed cleavage of released IL-1β by 284 
western blot and found that in HMDM levels of cleaved IL-1β were similar in samples infected 285 
with CFT073 and CFT073∆hlyA (Fig. 7D). In contrast, CFT073∆hlyA was drastically impaired 286 
in its ability to induce the release of cleaved IL-1β in BMM.7B). Deletion of sat or vat had no 287 
effect on IL-1β release from either human or mouse macrophages, and the response to the triple-288 
mutant was again identical to that of the hlyA single-mutant. Thus, α-hemolysin is the primary, 289 
but not only, mediator of cell death and IL-1β release in mouse macrophages. Moreover, 290 
generation of mature IL-1β was completely dependent on α-hemolysin. By contrast, in the 291 
human macrophage response to UPEC, α-hemolysin does not contribute to IL-1β release or 292 
cleavage, and plays only a minorlesser role in rapid cell death. These differential effects of α-293 
hemolysin further highlight the divergent UPEC recognition pathways of human and mouse 294 
macrophages. In summary, UPEC triggers both NLRP3-independent cell death and α-295 
hemolysin-independent IL-1β processing in human macrophages, thus indicating that additional 296 
host and pathogen-derived factors are likely to be important in the macrophage response to 297 
UPEC. 298 
 299 
  300 
Page 61 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
 
 15
301 
Page 62 of 86
Nature Publishing Group
Mucosal Immunology
For Peer Review
 
 16
Discussion 302 
To our knowledge,In this is the first report describing the ability of study, we demonstrate that 303 
some UPEC tostrains can trigger both NLRP3-dependent inflammasome responses activation 304 
and rapid cell death in macrophages. We also provide important insights into these processes in 305 
the context of similarities and differences between human and mouse macrophage responses to 306 
UPEC. Other E. coli, including enterohemorrhagic E. coli isolates12 as well as non-pathogenic or 307 
commensal stains
24, 2525, 26
, have been reported to activate inflammasomes by a variety of 308 
different mechanisms involving several bacterial factors. These include nucleic acids
2627
 and 309 
protein toxins (enterohemolysin
12
 and heat-labile enterotoxin
27
) acting via NLRP3, the T3SS rod 310 
protein EprJ
28
 and flagellin
24
 acting via NLRC4 and (intracellular) LPS
29
 acting via non-311 
canonical inflammasomes. Here we showed that the UPEC strains CFT073 and UTI89 induce 312 
rapid lytic cell death in primary human macrophages and correlated this response with their 313 
ability to elicit inflammasome activation.
28
) acting via NLRP3, the T3SS rod protein EprJ
29
 and 314 
flagellin25 acting via NLRC4 and (intracellular) LPS30 acting via non-canonical inflammasomes. 315 
Our study adds to this literature by identifying UPEC α-hemolysin-dependent and -independent 316 
mechanisms of inflammasome activation in macrophages.  317 
 318 
It remains unclear as to what roles UPEC-mediated inflammasome activation has in different 319 
pathophysiological contexts. Two out of the four strains that did not elicit inflammasome 320 
activation are associated with ABU
17, 1817, 18
, whilst the remaining two belong to the globally 321 
disseminated fluoroquinolone-resistant fimH30/clade C ST131 lineage that is frequently 322 
associated with symptomatic infection16, 3016, 31. The two inflammasome-activating strains are 323 
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also associated with UTI pathology. Hence, the capacity for inflammasome activation is variable, 324 
further highlighting the genetic diversity that exists amongst different UPEC isolates. Since the 325 
capacity to trigger inflammasome activation and macrophage cell death was not common to all 326 
UPEC strains, some UPEC strains may have gained inflammasome-activating factors as a 327 
component of their virulence mechanismsarmoury or lost these to avoid host detection. In the 328 
case of the former, candidate virulence factors included the pore forming toxin α-hemolysin3132, 329 
as well as serine-protease autotransporter toxins (Sat and Vat) that are known to elicit cytotoxic 330 
effects on epithelial cells
32
, and for which the genes are present in CFT073 and UTI89 but not 331 
83972, VR50
33
 or EC958
15
.
33
, and for which the genes are present in CFT073 (hlyA, sat, vat) and 332 
UTI89 (hlyA, vat), but not 83972, VR5034 or EC95815. Mutation of all three factors in CFT073 333 
revealed that only the absence of α-hemolysin substantially reduced inflammasome responses in 334 
mouse macrophages. Intriguingly, however, CFT073-triggered IL-1β release and cleavage was 335 
completely independent of α-hemolysin in human macrophages, and there was also a 336 
pronounced α-hemolysin-independent cell death pathway. This finding points towards 337 
fundamentally different recognition mechanisms for these UPEC strains in human versus mouse 338 
macrophages, yet conservation in the overall outcomes. Whether this extends to other cell types 339 
needs to be further examined, given an earliera recent report on E. coli α-hemolysin triggering 340 
IL-1β secretion in human urothelial cells
35
, an earlier study showing a similar phenomenon in 341 
human monocytes
36
 and well documented cell type-specific effects of α-hemolysin
3132
. 342 
 343 
Our aim to characterize the specific inflammasome involved in UPEC recognition led us to study 344 
the response of mouse macrophages as a more tractable genetic system, as compared to human 345 
macrophages. Initial experiments revealed that mouse and human macrophages seemed to 346 
Field Code Changed
Field Code Changed
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respond similarly with regard to induction of cell death, caspase-1 cleavage and IL-1β secretion 347 
upon infection with CFT073. In the case of UTI89, a much less pronounced response was 348 
observed in mouse macrophages compared to human macrophages, when using a low MOI (MOI 349 
10). Nonetheless, a 10-fold higher MOI did initiate some cell death in these cells. In contrast, 350 
both CFT073 and UTI89 had similar effects on human macrophages. The conservation between 351 
human and mouse macrophage responses to CFT073 led us to focus on this particular strain for 352 
the identification of host mechanisms mediating cellular responses. NLRP3, ASC and the 353 
inflammatory caspases (1 and/or 11) were indispensable for CFT073-mediated rapid lytic cell 354 
death and IL-1β secretion in mouse BMM, while a role for NLRC4 was excluded. These 355 
findings are consistent with a very recent study showing that UTI89 induces moderate IL-1β 356 
release from mouse macrophages in an NLRP3-dependent manner, albeit under different 357 
experimental conditions
37
. 358 
 359 
The conclusion that the acute CFT073-mediated inflammasome response leading to cell death 360 
and IL-1β secretion in BMM was absolutely dependent on NLRP3 was also supported by 361 
experiments using small molecule inhibitors of NLRP3 (MCC950) and caspase-1 (VX-765). 362 
However, primary human macrophages that were analysed in parallel showed a remarkably 363 
different response. The NLRP3 and caspase-1 inhibitors substantially reduced or blocked IL-1β 364 
secretionrelease from HMDM in response to UPEC infection or the NLRP3 agonist nigericin, 365 
respectively. In contrast, UPEC-triggered cell death was largely unaffected by either inhibitor. 366 
Although analysis of HMDM generated from several donors revealed some variation in the level 367 
of NLRP3-dependence, the overall conclusion is that in human macrophages cell death is 368 
NLRP3-independent, whereas IL-1β release always shows at least some NLRP3-369 
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dependence.cleavage was shown to be completely NLRP3-dependent. Interestingly, LPS-primed 370 
HMDMs released unprocessed IL-1β upon UPEC infection, even when the NLRP3 371 
inflammasome was blocked. Biologically, this may be of significance since it was shown that 372 
uncleaved IL-1β can be processed in the extracellular space by inflammasome complexes
38
 or by 373 
enzymes such as cathepsin-G and elastase39. Consistent with the existence of an NLRP3-374 
independent death pathway in human macrophages, stable knockdown of NLRP3 in THP-1 cells 375 
blocked LPS/nigericin-induced cell death, but only marginally reduced CFT073- and UTI89-376 
mediated cell death. GivenWhether NLRP3-independent cell death involves activation of another 377 
inflammasome is unknown at this stage. However, given that NLRP3 inhibition ablated both 378 
UPEC-triggered ASC speck formation still occurred to some extentinduced IL-1β maturation 379 
and caspase-1 cleavage in HMDM after blocking NLRP3 function, a, other modes of cell death 380 
such as necroptosis would appear to be more likely explanation is the existence of another 381 
UPEC-sensing inflammasome in. 382 
  383 
Divergence in the repertoire of NLR family members between human macrophages. Human 384 
versusand mouse can contribute to differences in UPEC-triggered inflammasome responses 385 
could potentially be explained by divergence in the repertoire of NLR family members between 386 
these species10, 3440. However, differences in the recognition of pathogens by orthologous human 387 
and mouse NLRs have also been reported. For example, F. tularensis activates only the AIM2 388 
inflammasome in mouse macrophages, but triggers NLRP3- and AIM2-dependent responses in 389 
human macrophages
35
.
41
. Conversely, L. monocytogenes was reportedly recognized by AIM2, 390 
NLRP3 and NLRC4 in mouse cells
36-3842-44
, but exclusively by NLRP3 in human cells
3945
. The 391 
causes for these differences are not fully understood, but may be related to species differences in 392 
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ligand recognition. siRNA screens of likely inflammasome candidates in human macrophages 393 
have thus far failed to identify the responsible host recognition system. Furthermore, other 394 
modes of cell death such as necroptosis cannot be discounted at this stage.Our study highlights 395 
that one pathogen can activate NLRP3 in both human and mouse macrophages, but through 396 
distinct mechanisms. Our demonstration of α-hemolysin-dependent IL-1β cleavage and cell 397 
death in mouse macrophages is consistent with a recent study showing α-hemolysin-mediated 398 
inflammasome activation in UTI89-infected mice
35
. In stark contrast however, our studies with 399 
human macrophages identified an α-hemolysin-independent pathway to IL-1β maturation. This 400 
suggests that another UPEC factor selectively promotes NLRP3 activation in human but not 401 
mouse macrophages, or that its relative potency in triggering inflammasome responses differs 402 
between these species or between different cell types.  403 
 404 
The selective role of NLRP3 in promoting IL-1β release but not cell death in human 405 
macrophages responding to UPEC suggestsEmerging evidence indicates that cytokine processing 406 
and pyroptosis can be uncoupled. This is reminiscent of recent studies of mouse neutrophils, 407 
where in some systems. For example, Salmonella-mediated NLRC4 activation promoted IL-1β 408 
maturation but not pyroptosis
40
 in mouse neutrophils
46
. Other studies have also reported distinct 409 
roles for individual inflammasomes in cytokine processing versus pyroptosis. For example, 410 
NLRP3 was shown to mediate cell death and IL-1β release in S. aureus-infected HMDM, whilst 411 
a novel NLRP7 inflammasome was shown to selectively promote IL-1β secretion
41
.
47
. Similarly, 412 
NLRP3 and NLRC4 were shown to mediate B. pseudomallei-induced IL-1β and IL-18 release in 413 
the mouse, whilst pyroptotic cell death was attributed only to NLRC4
42
.
48
. At present, there is no 414 
unifying model explaining why similar recognition systems lead to cytokine maturation in one 415 
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setting, and pyroptosis in another. Broz et al. proposed that CARD-containing NLRs form a 416 
cytokine processing inflammasome in the presence of ASC, but a death complex directly with 417 
caspase-1 in its absence
21
.can initiate distinct complexes with different roles in mediating 418 
cytokine maturation versus pyroptotic cell death
22
. However, the above described mechanism 419 
does not apply for most NLRPs and AIM2, which contain a pyrin domain rather than a CARD10, 420 
and does not explain how death and cytokine responses happen simultaneously in the presence of 421 
ASC. The fact that NLRP3 was causal for cytokine processing but not cell death in human 422 
macrophages might again be interpreted as another example of uncoupling of downstream 423 
inflammasome responses. However, it would seem more likely that the NLRP3-independent cell 424 
death pathway overrides NLRP3-dependent pyroptosis in our system.  425 
 426 
A protective role for inflammasome activation and IL-1β production has been shown in many in 427 
vivo infection models including S. Typhimurium, L. monocytogenesis and Burkholderia species11 428 
On the other hand, the role of pathogen-induced cell death is ambiguous, having either protective 429 
or detrimental effects by either eradicating intracellular niches or promoting dissemination, 430 
respectively
43
. Since UPEC can occupy both extracellular and intracellular niches, it is difficult 431 
to predict what role pyroptosis plays during UTI. Approaches for genetically and/or 432 
pharmacologically uncoupling pyroptosis from other inflammasome responses will be required 433 
to address this question. In the case of cytokine processing, previous studies have associated IL-434 
1β release with renal pathology of UTI in patients
44, 45
 and in a mouse model
46
. Whether NLRP3 435 
has a causal role in host defence or pathology is unknown at this stage. Given differences 436 
between human and mouse macrophages in NLRP3-dependence for UPEC responses, this is not 437 
a trivial task. 49. Since UPEC can occupy both extracellular and intracellular niches, it is difficult 438 
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to predict what role pyroptosis plays during UTI. Activation of caspase-1/11 was shown to 439 
facilitate clearance of UPEC in a mouse model, presumably by inducing pyroptosis and 440 
subsequent exfoliation of bladder epithelial cells
35
. In another study however, activity of caspase-441 
1/11 was associated with chronicity and higher bacterial loads in the bladder in a model of 442 
recurrent UTI
50
. In the case of cytokine processing, previous studies have associated IL-1β 443 
release with renal pathology of UTI in patients
51, 52
, and also in a mouse model
53
. Only very 444 
recently was IL-1β release in atg16l1-/- mice shown to be associated with protection from UTI
37
. 445 
While the effects of IL-1β can be studied simply by knockout or by blocking its interaction with 446 
receptors, new approaches for genetically and/or pharmacologically uncoupling pyroptosis from 447 
other inflammasome responses will be required to address the role of cell death in pathology. 448 
Whether NLRP3-dependent responses have a causal rol  in host defence or pathology remains to 449 
be elucidated. 450 
 451 
In conclusion, our study highlights the complexity of interactions between UPEC and the innate 452 
immune system. Some UPEC strains trigger inflammasome activation and rapid, lytic cell death 453 
in macrophages, whereas others, including two strains from the globally disseminatedmultidrug 454 
resistant ST131 lineage, do not. Further, whereasThis again highlights the genetic complexity 455 
that exists amongst different UPEC-mediated cell death  strains and IL-1β secretion are mediated 456 
bythat host response pathways engaged, as well as host colonization strategies employed, will 457 
vary depending on the specific UPEC strain encountered. For inflammasome-activating strains 458 
such as CFT073, NLRP3 indrives IL-1β maturation in both human and mouse macrophages. 459 
However, this pathway only partlymarginally contributes to IL-1β maturationcell death in human 460 
macrophages, despite its causal role in cell death in mouse macrophages. Finally, α-hemolysin is 461 
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the primary trigger for cell death and IL-1β release in mouse macrophages, whereas these 462 
cellular responses are either primarily or completely independent of this toxin in human 463 
macrophages. The yet-to-be-identified death pathway in human monocyte-derived macrophages 464 
highlights a keypotential difference between human and mouse innate immune UPEC 465 
recognition pathways. and needs to be considered in future studies using macrophages and other 466 
cell types from a variety of sources, as well as in in vivo studies. Given the importance of mouse 467 
UTI models for understanding host colonization and pathology, and especially in the light of 468 
recent studies showing detrimental and beneficial effects of inflammasome activation in mouse 469 
models
37, 50
, as well as a prominent role for α-hemolysin
35
, our findings are likely to have broad 470 
significance for understanding susceptibility and severity of UTI in humans.   471 
 472 
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Methods 491 
 492 
Bacterial strains and growth conditions  493 
UPEC strains CFT073
13
, UTI89
14
, 83972
17
, VR50
18
 and EC958
1515
 have been described 494 
previously. MS3179 is an ST131 strain isolated from a patient presenting with UTI at the Royal 495 
Brisbane and Women’s Hospital, Brisbane, Australia. S. Typhimurium strain SL13444754 was 496 
used as a control for NLRP3-independent inflammasome activation in some experiments. All 497 
strains were routinely grown at 37˚C on solid or in liquid Luria-Bertani (LB) medium. 498 
 499 
Genetic manipulation procedures and generation of mutants 500 
Mutation of the hlyA, sat and vat genes in CFT073, and the hlyA gene in UTI89, was performed 501 
using the λ-Red recombinase gene replacement system
4855
. The primers used for amplification of 502 
the kanamycin resistance gene (hlyA) or chloramphenicol resistance gene (vat, sat), and 503 
subsequent insertion into the chromosome of CFT073 (or UTI89) were as follows: vat (3353: 5’-504 
tcgtaatgaacacagttcatctgatctccacacaccaagacttgataagctcacgtcttgagcgattgtgtagg and 3354: 5’-505 
gaaaccaccaccccatgattttgttttaccgctgtacaggcctgctgacgcgacatgggaattagccatggtcc), sat (3351: 5’-506 
aagaaattccaatgattttgagattcagaggttaaataaatttgttgtggacacgtcttgagcgattgtgtagg and 3352: 5’-507 
ccaggagtgggagctgtagtctctggtgccaaggccggcgaaagttgcggtgacatgggaattagccatggtcc), hlyA (2049: 5’-508 
aaattaaaagcacactacagtctgcaaagcaatcctctgcaaataaattgtgtaggctggagctgcttc and 2050: 5’-509 
tgctctgctgctttttttaatgcatctttcgtgctttgtcctgctgagtgcatatgaatatcctccttag). CFT073 hlyA 510 
(CFT073∆hlyA), sat (CFT073∆sat) and vat (CFT073∆vat) mutants, as well as the UTI89 hlyA 511 
mutant (UTI89∆hlyA), were confirmed by PCR and DNA sequencing. The CFT073hly-sat-vat 512 
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triple mutant was constructed by sequential deletion of each gene, as described above, and was 513 
conﬁrmed by PCR and DNA sequencing.  514 
 515 
Mammalian cell culture  516 
Approval for all experiments using primary human and mouse cells was obtained from the 517 
University of Queensland Medical Research Ethics Committee  or the Animal Ethics Committee. 518 
Human monocytes were isolated from buffy coats of healthy donors (kindly provided by the 519 
Australian Red Cross) by positive selection for CD14 using MACS technology (Miltenyi Biotec, 520 
Bergisch Gladbach, Germany), as previously described
49
.
56
. HMDM were differentiated for 7 521 
days with CSF-1 (10,000 U/ml, Chiron Emeryville, CA, USA) from CD14+ cells, as previously 522 
described
4956
, but in the absence of antibiotics. Cells from a single donor were used in every 523 
experiment. Murine BMM were differentiated using 10,000 U/ml CSF-1 (Chiron) from bone 524 
marrow of C57BL/6 wild type, Nlrp3-/- , Nlrc4-/- , Asc-/- , and Caspase-1/11-/- mice (all described 525 
in
4046
), in the absence of antibiotics as previously described
6
. PCC were flushed from the 526 
peritoneal cavity of C57BL/6 mice by injection of 5 ml PBS. THP-1 (TIB-202, ATCC, 527 
Manassas, VA, USA), THP-1 Null and THP-1 defNLRP3 (InvivoGen, San Diego, CA, USA) 528 
cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 1 529 
mM Na-Pyruvate and 10 mM HEPES (all Life Technologies, Carlsbad, CA, USA). THP-1 cells 530 
were differentiated into macrophage-like cells by culture for 48 h in medium containing 30 ng/ml 531 
phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich, St. Louis, MO, USA). PMA or CSF-1 532 
was removed 4 h prior to infection with UPEC strains. Human bladder epithelial cell lines 533 
56345637 (HTB-9, ATCC) and T24 (HTB-4, ATCC) were cultured in FBS (10%) and 2 mM L-534 
glutamine supplemented RPMI-1640 or McCoy’s 5A medium (Life Technologies), respectively.    535 
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 536 
Bacterial culture and macrophage infection assays 537 
UPEC strains were grown statically at 37˚C overnight in LB broth. S. Typhimurium strain 538 
SL1344 was grown overnight in LB broth (200 rpm, 37˚C), diluted 1:33 and grown for another 3 539 
h (to ensure logarithmic growth). Cells were pelleted, washed and adjusted to the same optical 540 
density at 600 nm. A MOI of approximately 10 was used (unless indicated otherwise) and 541 
confirmed by enumeration of colony forming units following serial dilution. Mammalian cells 542 
were seeded at a density of 4-8x10
4
/0.2 ml in 96-well plates or 2-4x10
5
/ml in 24-well plates 543 
(Nunc, Roskilde, Denmark). Medium was changed for all cell types to RPMI-1640 supplemented 544 
with FBS (10%) and 2 mM L-glutamine (all Life Technologies) 4 h prior to infection. LPS-545 
priming was performed by addition of 100 ng/ml Ultrapure LPS from Salmonella minnesota 546 
R595 (InvivoGen). Nigericin sodium salt (Sigma-Aldrich) at a concentration of 10 µM was used 547 
as a positive control for NLRP3-dependent responses. In some experiments, cells were pre-548 
incubated for 1 h with the caspase-1 inhibitor VX-765 (Selleck Chemicals, Houston, TX, USA) 549 
or the NLRP3 inhibitor MCC95022, prior to performing infections.23, prior to performing 550 
infections. At 1 h post-infection, 200 µg/ml gentamicin (Life Technologies) was added for 1 h to 551 
inhibit growth of extracellular bacteria. For infections over a 24 h time course, medium was 552 
replaced with fresh medium containing 20 µg/ml gentamicin for the remaining 22 h. 553 
 554 
Cytotoxicity assays 555 
Cell culture supernatants were collected at 2 or 24 h post-infection, centrifuged for 5 min at 500 556 
g, and analysed for LDH release using the In Vitro Toxicology Assay Kit (Sigma-Aldrich). 557 
Cytotoxicity (%) was calculated by quantification of LDH in culture supernatants versus total 558 
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cellular LDH (present in S/N after cell lysis with 0.1% Triton X-100) according to the formula % 559 
cell death = (100/LDHtotal-LDHspontaneous)x(LDHtreatment-LDHspontaneous). Values calculated at 24 h 560 
values represent summed measuresmeasurements of the same wellswell at 2 and 24 h post-561 
infection, since medium was changed at 2 h post-infection (see aboveas part of the gentamicin 562 
exclusion protocol (see: Bacterial culture and macrophage infection assays).  563 
 564 
Confocal microscopy 565 
Confocal microscopy was performed as previously described
6
. Cells were stained with 200 ng/ml 566 
Alexa Fluor® 594 Phalloidin (Life Technologies) to visualize cell morphology, and ASC was 567 
detected with a rabbit anti-ASC Antibody (N-15)-R (Santa Cruz Biotechnology, Santa Cruz, CA) 568 
(1:300) and Alexa Fluor® 647 or 688-conjugated chicken anti-Rabbit IgG (Life Technologies) as 569 
a secondary antibody (1:150). For quantifying ASC speck formation, HMDM were cultured in 570 
12 mM glycine to reduce loss of cells due to lytic cell death50.57. ASC specks were counted 571 
manually in a blinded fashion (5 fields at 40x magnification per condition per replicate). 572 
 573 
Immunoblotting 574 
4x10
5 
cells were lysed in 100 µl 2xSDS loading buffer (125 mM Tris-HCl, 20% glycerol (v/v), 575 
4% SDS (w/v), pH 6.8). For analysis of secreted caspase-1 in cell culture supernatants, medium 576 
was replaced with OptiMEM medium (Life Technologies) 4 h prior to infection. Cell culture 577 
supernatants were precipitated by incubation with 4 volumes of acetone at -20˚C overnight and 578 
centrifugation at 5300 g and -10˚C for 30 min. Pellets were taken up in 2xSDS loading buffer. 579 
Western blotting was performed as previously described
49
.
56
. Membranes were stained with 580 
cleaved IL-1β (Asp116) rabbit mAb, IL-1β (3A6) mouse mAb, cleaved caspase-1 (ASP297) 581 
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(D57A2) rabbit mAb (all Cell Signalling Technology, Danvers, MA, USA), mouse IL-1β/IL-1F2 582 
affinity purified polyclonal Ab, Goat IgG (R&D Systems, Minneapolis, MN, USA), anti-583 
caspase-1 (p20) (mouse) mAb (Adipogen, San Diego, CA, USA), anti-NLRP3/NALP3 mAb 584 
(Cryo-2) (Adipogen) or human anti-G3PDH antibody (Trevigen, Gaithersburg, MD, USA). All 585 
primary antibodies were diluted 1:1000 except for human anti-G3PDH antibody, which was used 586 
at 1:10000. As secondary antibodies, anti-mouse and anti-rabbit IgG, HRP-linked Antibodies 587 
(Cell Signalling Technology) were used (1:2500).(1:2500) and anti-goat IgG-peroxidase 588 
antibody (Sigma-Aldrich) (1:5000) were used. HRP was detected using ECL Plus substrate (GE 589 
Healthcare, Buckinghamshire, UK) and Super RX film (Fujifilm, Tokyo, Japan).  590 
 591 
ELISA 592 
Cell culture supernatants were analysed for IL-1β with the human or mouse IL-1β/IL-1F2 593 
DuoSet ELISA kit (R&D Systems, Minneapolis, MN, USA) (detection limit 4 and 15.6 pg/ml, 594 
respectively) and anti-human or mouse ELISA Ready-Set-Go! (eBiosciece, San Diego, CA, 595 
USA).) (detection limit: 4 and 8 pg/ml, respectively). TNF-α was detected using the Mouse TNF 596 
OptEIA ELISA set (BD Biosciences, San Diego, CA, USA) (detection limit: 15.6 pg/ml) and the 597 
human TNF-α standard ELISA Developmental kit (Peprotech, Rocky Hill, NJ, USA) (detection 598 
limit: 16 pg/ml) .  599 
 600 
Statistical Analysis 601 
All LDH, ELISA and MTT assays were performed using duplicate or triplicate cell culture wells 602 
for individual experiments. Presented data are typically mean values combined from three or 603 
more independent experiments, unless otherwise indicated. For statistical analysis of datasets 604 
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with N>4, two-sided Wilcoxon matched-pairs signed-rank tests were performed using GraphPad 605 
Prism Version 6 (GraphPad software, Inc., La Jolla, CA, USA). For these datasets, the 606 
differences between pairs were plotted and were generally distributed approximately 607 
symmetrically around the median.  608 
 609 
610 
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Figure legends 862 
 863 
Figure 1: The UPEC strains CFT073 and UTI89 induce rapid cell death in macrophages. 864 
A-C) HMDM or BMM were infected with the indicated UPEC strains (MOI 1, 10 and 100). 865 
Supernatants were analyzed by LDH release assays at the indicated times. post-infection (p.i.). 866 
Data represent the mean+SEM of three independent experiments. D) Human macrophage-like 867 
cells (THP-1) and mouse peritoneal cavity cells (PCC), as well as the human T24 and 5637 868 
bladder epithelial cell lines (T24 and 5637),cells, were infected with the indicated UPEC strains 869 
(MOI 10) for 2 h. Supernatants were analyzed by LDH release assay. Data represent the 870 
mean+range of two independent experiments. 871 
 872 
Figure 2: The UPEC strains CFT073 and UTI89 promote IL-1β secretion, caspase-1 873 
cleavage and ASC-speck formation. A) HMDM and BMM were primed with 100 ng/ml LPS 874 
for 4 h, then infected with the indicated UPEC strains (MOI 10) for 2 h. Supernatants were 875 
analyzed by ELISA. Data represent the mean+SEM of three independent experiments. B) 876 
HMDM and BMM were infected with the indicated UPEC strains for 1 h. Whole cell lysates and 877 
concentrated supernatants were analyzed by western blot with antibodies detecting human or 878 
mouse caspase-1 p20. GAPDH is shown as a loading control. Similar findings were apparent in 879 
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three independent experiments. C) HMDM were infected with the indicated UPEC strains (MOI 880 
10) for 2 h, after which they were fixed and analyzed by confocal microscopy. Arrowheads 881 
indicate ASC-specks. Similar results were apparent in two independent experiments. 882 
 883 
Figure 3: In murine macrophages, CFT073-induced caspase-1 cleavage and cell death is 884 
dependent on the NLRP3 inflammasome. BMM derived from wild type, Nlrp3-, Nlrc4-, Asc- 885 
and Casp1/11-deficient mice were infected with the UPEC strain CFT073 or the S. Typhimurium 886 
strain SL1344 (MOI 10), or were stimulated with nigericin (10 µM, pre-stimulated with 100 887 
ng/ml LPS for 4 h). A) After 1 h, whole cell lysates and concentrated supernatants were analyzed 888 
by western blot with antibodies detecting murine full-length caspase-1, as well as multiple 889 
caspase-1 cleavage products. GAPDH was used as loading control. Data is representative of two 890 
independent experiments. B) Supernatants were analyzed by LDH assay at 2 h p.i. Data is the 891 
mean+range of two independent experiments. C) LPS-primed BMM (100 ng/ml, 4 h) were 892 
treated as above, after which secreted IL-1β was measured by ELISA after 2 h. Data are 893 
mean+SEM of three independent experiments. 894 
 895 
Figure 4: NLRP3 partially contributes to IL-1β release and maturation andbut does not 896 
mediate cell death in human macrophages responding to CFT073. A-B) HMDM were 897 
primed with LPS (100 ng/ml, 4 h),) or left untreated, then pretreated for 1 h with the NLRP3 898 
inhibitor MCC950 (10 µM) and then subsequently infected with the UPEC strain CFT073 or S. 899 
Typhimurium SL1344 (MOI 10), or were stimulated with nigericin (10 µM). Supernatants were 900 
collected at 2 h p.i., and analyzed by LDH release assay (A)  and ELISA (B). Data are from nine 901 
(CFT073, LPS/nigericin) and six (S. Typhimurium) independent experiments (different donors), 902 Formatted: Font: Italic
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respectively. Statistical analysis was performed using a Wilcoxon matched-pairs signed-rank 903 
tests: ns: p> 0.05, *: p<=0.05, **: p<=0.01. CC) Concentrated supernatants from cells treated as 904 
described above were analyzed by western blot with antibodies detecting full-length or cleaved 905 
human IL-1β. D) HMDM were treated as above, but in presence of 12 mM glycine, and analyzed 906 
by confocal microscopy. ASC specks and nuclei were counted manually in a blinded manner. 907 
Data are mean+SEM of three independent experiments. 908 
 909 
Figure 5: UPEC-mediated cell death is blocked by caspase-1 inhibition in mouse but not 910 
human macrophages. A-B) HMDM and BMM were primed with LPS (100 ng/ml, 4 h),) or left 911 
untreated, then pretreated for 1 h with the caspase-1 inhibitor VX-765 (50 µM), and 912 
subsequently infected with the UPEC strain CFT073 (MOI 10) or were stimulated with nigericin 913 
(10 µM). Supernatants were collected at 2 h p.i., and were analyzed for cell death by LDH 914 
release assay (A) and IL-1β release by ELISA (B). Data represent the mean+SEM of three 915 
independent experiments. (C-D) HMDM and BMM were treated as above for 1 h. Cell lysates, 916 
as well as cell culture supernatants, were analyzed by western blot for cleavage of caspase-1. 917 
GAPDH served as loading control. Similar results were obtained in two independent 918 
experiments. 919 
 920 
Figure 6: UPEC triggers NLRP3-independent cell death in human macrophages. Stable 921 
NLRP3 knockdown THP-1 cells (defNLRP3), as well as THP-1 control cells (Null) were 922 
infected with the indicated UPEC strains or S. Typhimurium (MOI 10), or were treated with 923 
nigericin (10 µM) for 1 h (A) or 2 h (B). A) Cell lysates were analyzed by western blot for 924 
expression of NLRP3 and GAPDH as a loading control. Caspase-1 p20 was detected in cell 925 
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lysates. Similar findings were apparent in two independent experiments. B) Supernatants of 926 
unprimed or LPS primed (100 ng/ml LPS, 4 h) THP-1 cells were analyzed by LDH assay. Data 927 
are the mean+SEM of threefour independent experiments.  928 
 929 
Figure 7: Differences between human and mouse macrophages in cellular responses to the 930 
toxin α-hemolysin. A-B) HMDM and BMM were infected with wild type CFT073, 931 
CFT073UPEC strains or mutants deficient for α-hemolysin  (∆hlyA), sat (∆sat), vat (∆vat) or all 932 
three genes (∆hlyA;∆sat;∆vat) at athe indicated MOI 10 for 2 h. A) Supernatants were analyzed 933 
by LDH assay. BC) LPS–primed (100 ng/ml, 4 h) cells were treated as above (MOI 10) and 934 
analyzed by IL-1β ELISA. Data are the mean+SEM of three (A, C) or four (B) independent 935 
experiments. D) Concentrated supernatants from cells treated as described above were analyzed 936 
by western blot with antibodies detecting cleaved human or mouse IL-1β. Similar observations 937 
were made in 2 independent experiments. 938 
 939 
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